Prof. Dr. Enikeev

1. PROGNOSTIC VALUE OF T1 SUBSTAGING ON ONCOLOGICAL OUTCOMES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER UROTHELIAL CARCINOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. Kardoust Parizi M, Enikeev D, Glybochko PV, Seebacher V, Janisch F, Fajkovic H, Chłosta PL, Shariat SF. World J Urol. 2019 Sep 6. doi: 10.1007/s00345-019-02936-y. [Epub ahead of print] PubMed PMID: 31493109.
2. SIX ESSENTIAL CONDITIONS FOR BLADDER-SPARING STRATEGIES IN BACILLUS CALMETTE-GUÉRIN UNRESPONSIVE BLADDER CANCER. Shariat SF, Enikeev DV,Mostafaei H. 2019 Sep;11(13):1083-1086. doi: 10.2217/imt-2019-0083. Epub 2019 Aug 6. PubMed PMID: 31385744.
3. PROGNOSTIC ROLE OF THE UROKINASE PLASMINOGEN ACTIVATOR (UPA) SYSTEM IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER. Iwata T, Kimura S, Abufaraj M, Janisch F, Parizi MK, Haitel A, Rink M, Rouprêt M, Fajkovic H, Seebacher V, Nyirady P, Karakiewicz PI, Enikeev D, Rapoport LM, Nasu Y, Shariat SF. Urol Oncol. 2019 Oct;37(10):774-783. doi: 10.1016/j.urolonc.2019.05.019. Epub 2019 Jun 27. PubMed PMID: 31255543.
4. EN BLOC RESECTION FOR NONMUSCLE INVASIVE BLADDER CANCER: REVIEW OF THE RECENT LITERATURE. Mori K, D'Andrea D, Enikeev DV, Egawa S, Shariat SF. Curr Opin Urol. 2020 Jan;30(1):41-47. doi: 0.1097/MOU.0000000000000697. PubMed PMID: 31724997.
5. DIFFERENTIAL EFFECT OF SEX ON OUTCOMES AFTER RADICAL SURGERY FOR UPPER TRACT AND BLADDER UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Mostafaei H, Enikeev DV, Lysenko I, Quhal F, Kimura S, Karakiewicz PI, Egawa S, Shariat SF. J Urol. 2020 Jan 29:101097JU0000000000000788. doi: 10.1097/JU.0000000000000788. [Epub ahead of print]. PMID: 31995432
6. COMPARATIVE EFFECTIVENESS OF INTRAVESICAL BCG-TICE AND BCG-MOREAU IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER. D'Andrea D, Soria F, Abufaraj M, Pones M, Gontero P, Machado AT, Waksman R, Enikeev DV, Glybochko PV, Adonias SP, Nahas WC, Shariat SF, Chade DC. Clin Genitourin Cancer. 2020 Feb;18(1):20-25.e2. doi: 10.1016/j.clgc.2019.10.021. Epub 2019 Nov 6. PMID: 31786120
7. THE PROGNOSTIC VALUE OF THE UROKINASE-PLASMINOGEN ACTIVATOR SYSTEM (UPA) IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY (RC). Janisch F, D'Andrea D, Iwata T, Kimura S, Abufaraj M, Enikeev D, Glybochko PV, Karakiewicz PI, Nyirady P, Fajkovic H, Haitel A, Seebacher V, Rink M, Shariat SF. Urol Oncol. 2020 Mar 21. pii: S1078-1439(20)30043-0. doi: 10.1016/j.urolonc.2020.02.002. [Epub ahead of print]. PMID: 32209281
8. NOVEL TECHNOLOGIES THAT CHANGE THE DIAGNOSTIC AND TREATMENT PARADIGM IN UROLOGY: EN-BLOC AS THE NEW TREATMENT STANDARD. Enikeev D, Shariat SF. Curr Opin Urol. 2020 May;30(3):475-476. doi: 10.1097/MOU.0000000000000747. No abstract available. PMID: 32235286
9. The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis.  Sari Motlagh R, Mori K, Miura N, Quhal F, Aydh A, Laukhtina E, Pradere B, Karakiewicz PI, Enikeev DV, Deuker M, Shariat SF.  BJU International. DOI: 10.1111/bju.15146
10. Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC).  Laukhtina E, Mostafaei H, D'Andrea D, Pradere B, Quhal F, Mori K, Miura N, Schuettfort VM, Sari Motlagh R, Aydh A, Abufaraj M, Karakiewicz PI,Enikeev D, Kimura S, Shariat SF. World Journal of Urology. DOI: 10.1007/s00345-020-03384-9
11. Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser en Bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial.  Enikeev, D., Taratkin, M., Margulis, V., Sorokin, N., Severgina, L., Paramonova, N., Kislyakov, D., Kozlov, V., Rapoport, L., Shariat, S.F., Glybochko, P. Bladder Cancer, 6 (2), pp. 201-210. 10.3233/BLC-200275
12. Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method. Glukhov A, Potoldykova N, Taratkin M, Gordeev S, Polyakovsky K, Laukhtina E, Moschini M, Abufaraj M, Shariat SF, Sekacheva M, Enikeev D, Glybochko P. J Clin Med. 2021 Mar 4;10(5):1055. doi: 10.3390/jcm10051055.
13. Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence. Laukhtina E, Abufaraj M, Al-Ani A, Ali MR, Mori K, Moschini M, Quhal F, Sari Motlagh R, Pradere B, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Fajkovic H, Soria F, Enikeev D, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Eur Urol Focus. 2021 Mar 21:S2405-4569(21)00095-X. doi: 10.1016/j.euf.2021.03.016.
14. Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review. Laukhtina E, Pradere B, Mori K, Schuettfort VM, Quhal F, Mostafaei H, Sari Motlagh R, Aydh A, Moschini M, Enikeev D, Karakiewicz PI, Abufaraj M, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Urol Oncol. 2021 Apr 19:S1078-1439(21)00115-0. doi: 10.1016/j.urolonc.2021.03.005. 
15. Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis. Laukhtina E, Rajwa P, Mori K, Moschini M, D'Andrea D, Abufaraj M, Soria F, Mari A, Krajewski W, Albisinni S, Teoh JY, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NC, Enikeev D, Zimmermann K, Fajkovic H, Glybochko P, Shariat SF, Pradere B; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group (EAU YAU). Eur Urol Focus. 2021 Jun 11:S2405-4569(21)00162-0. doi: 10.1016/j.euf.2021.05.010. Online ahead of print.
16. Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis. Laukhtina E, Mori K, D Andrea D, Moschini M, Abufaraj M, Soria F, Mari A, Krajewski W, Albisinni S, Teoh JY, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NС, Rajwa P, Enikeev D, Zimmermann K, Fajkovic H, Glybochko P, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Urol Oncol. 2021 Jul 12:S1078-1439(21)00267-2. doi: 10.1016/j.urolonc.2021.06.009. Online ahead of print.
17. Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis. Laukhtina E, Mori K, Mostafaei H, Merseburger AS, Nyirady P, Moschini M, Quhal F, Schuettfort VM, Pradere B, Motlagh RS, Enikeev D, Shariat SF, Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group EA. 2021 Aug;13(11):917-929. doi: 10.2217/imt-2020-0305. Epub 2021 Jun 3.PMID: 34078134
18. Impact of the preoperative modified glasgow prognostic score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder. Schuettfort VM, Gust K, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. Minerva Urol Nephrol. 2021 Jun 11. doi: 10.23736/S2724-6051.21.04216-6. Epub ahead of print. PMID: 34114784.
19. Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials Laukhtina E, Mori K, Mostafaei H, Merseburger AS, Nyirady P, Moschini M, Quhal F, Pradere B, Motlagh RS, Enikeev D, Shariat SF; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Semin Oncol. 2021 Jun;48(3):181-192. doi: 10.1053/j.seminoncol.2021.09.005. Epub 2021 Oct 2. PMID: 34749886.
20. Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review Laukhtina E, Pradere B, Mori K, Schuettfort VM, Quhal F, Mostafaei H, Sari Motlangh R, Katayama S, Grossmann NC, Moschini M, Enikeev D, Shariat SF; European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Urol Oncol. 2021 Mar;39(3):180-190. doi: 10.1016/j.urolonc.2020.12.019. Epub 2021 Jan 8. PMID: 33423937.
21. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. Schuettfort VM, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF BJU Int. 2021 Mar 1. doi: 10.1111/bju.15379. Epub ahead of print. PMID: 33650265.
22. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer. Quhal F, Pradere B, Laukhtina E, Sari Motlagh R, Mostafaei H, Mori K, Schuettfort VM, Karakiewicz PI, Rouprêt M, Enikeev D, Rink M, Abufaraj M, Shariat SF. World J Urol. 2021 Sep;39(9):3345-3352. doi: 10.1007/s00345-020-03586-1. Epub 2021 Jan 26. PMID: 33496841; PMCID: PMC8510920.
23. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. Schuettfort VM, Pradere B, D'Andrea D, Grossmann NC, Quhal F, Mostafaei H, Laukhtina E, Mori K, Rink M, Karakiewicz PI, Motlagh RS, Katayama S, Lotan Y, Scherr D, Abufaraj M, Fajkovica H, Compérat E, Enikeev D, Shariat SF. J Urol. 2021 Nov;206(5):1122-1131. doi: 10.1097/JU.0000000000001936. Epub 2021 Jun 28. PMID: 34181469.
24. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis Laukhtina E, Shim SR, Mori K, D'Andrea D, Soria F, Rajwa P, Mostafaei H, Compérat E, Cimadamore A, Moschini M, Teoh JY, Enikeev D, Xylinas E, Lotan Y, Palou J, Gontero P, Babjuk M, Witjes JA, Kamat AM, Roupret M, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group Eur Urol Oncol. 2021 Nov 6:S2588-9311(21)00183-8. doi: 10.1016/j.euo.2021.10.003. Epub ahead of print. PMID: 34753702.
25. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta- Analysis Zhao H, Chan VW, Castellani D, Chan EO, Ong WLK, Peng Q, Moschini M, Krajewski W, Pradere B, Ng CF, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan WS, Kelly J, Shariat SF, Witjes JA, Teoh JY.. Front Surg. 2021 Nov 23;8:775527. doi: 10.3389/fsurg.2021.775527. PMID: 34888347; PMCID: PMC8649716.
26. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta- analysis of oncologic and toxicity outcomes. Laukhtina E, Motlagh RS, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Crit Rev Oncol Hematol. 2021 Dec 10:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub ahead of print. PMID: 34902554.
27. Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Laukhtina E, Schuettfort VM, D'Andrea D, Pradere B, Mori K, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NС, Rajwa P, Zeinler F, Abu Faraj M, Moschini M, Zimmermann K, Karakiewicz PI, Fajkovic H, Scherr D, Compérat E, Nyirady P, Rink M, Enikeev D, Shariat SF. Mol Carcinog. 2022 Jan;61(1):5-18. doi: 10.1002/mc.23355. Epub 2021 Sep 29. PMID: 34587660.
28. En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. Enikeev D, Babjuk M, Shpikina A, Shariat S, Glybochko P. Curr Opin Urol. 2022 Mar 1;32(2):173-178. doi: 10.1097/MOU.0000000000000968. PMID: 34954702.
29. Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group. Laukhtina E, Moschini M, Soria F, Andrea DD, Teoh JY, Mori K, Albisinni S, Mari A, Krajewski W, Cimadamore A, Abufaraj M, Enikeev D, Neuzillet Y, Giannarini G, Xylinas E, Kamat AM, Roupret M, Babjuk M, Witjes JA, Shariat SF, Pradere B; European Association of Urology; Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group; European Association of Urology Section of Oncological Urology ESOU. Eur Urol Focus. 2022 Mar 22:S2405-4569(22)00058-X. doi: 10.1016/j.euf.2022.03.004. PMID: 35337773.
30. How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey. Guven S, Colecchia M, Oltulu P, Bonfante G, Enikeev D, Esen H, Herrmann T, Lusuardi L, Micali S, Somani B, Skolarikos A, Breda A, Liatsikos E, Redorta JP, Gozen AS. World J Urol. 2022 May 14. doi: 10.1007/s00345-022-04022-2. PMID: 35567624.
31. Systematic Review: The Learning Curve for Robot-Assisted Radical Cystectomy-What Do We Know? Morozov A, Babaevskaya D, Taratkin M, Inoyatov J, Laukhtina E, Moschini M, Singla N, Gomez Rivas J, Teoh JY, Glybochko P, Enikeev D. J Endourol. 2022 Jun;36(6):770-784. doi: 10.1089/end.2021.0388. PMID: 35156854.
32. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study. Laukhtina E, Boehm A, Peyronnet B, Bravi CA, Batista Da Costa J, Soria F, D'Andrea D, Rajwa P, Quhal F, Yanagisawa T, König F, Mostafaei H, Enikeev D, Ingels A, Verhoest G, D'Hondt F, Mottrie A, Joniau S, Van Poppel H, de la Taille A, Bensalah K, Bruyère F, Shariat SF, Pradere B. World J Urol. 2022 Jul;40(7):1689-1696. doi: 10.1007/s00345-022-04025-z. PMID: 35596017; PMCID: PMC9236994.
33. Corrigendum to “Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis” [Eur Urol Oncol 2021;4:927-42]. Laukhtina E, Shim SR, Mori K, D’Andrea D, Soria F, Rajwa P, Mostafaei H, Compérat E, Cimadamore A, Moschini M, Teoh JY, Enikeev D, Xylinas E, Lotan Y, Palou J, Gontero P, Babjuk M, Witjes JA, Kamat AM, Roupret M, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists EAU-YAU Urothelial Carcinoma Working Group. Eur Urol Oncol. 2022 Aug;5(4):480-481. Doi: 10.1016/j.euo.2022.01.003. PMID: 35063436.
34. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Crit Rev Oncol Hematol. 2022 Jan;169:103570. doi: 10.1016/j.critrevonc.2021.103570.
35. Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate. Laukhtina E, Moschini M, Krajewski W, Teoh JY, Ploussard G, Soria F, Roghmann F, Muenker MA, Roumiguie M, Alvarez-Maestro M, Misrai V, Antonelli A, Tafuri A, Simone G, Mastroianni R, Zhao H, Rahota RG, D'Andrea D, Mori K, Albisinni S, Karakiewicz PI, Fajkovic H, Enikeev D, Montorsi F, Shariat SF, Pradere B; European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. BJU Int. 2022 Sep 22. doi: 10.1111/bju.15898. 
36. A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond. Leow JJ, Tan WS, Tan WP, Tan TW, Chan VW, Tikkinen KAO, Kamat A, Sengupta S, Meng MV, Shariat S, Roupret M, Decaestecker K, Vasdev N, Chong YL, Enikeev D, Giannarini G, Ficarra V, Teoh JY; UroSoMe Collaborators. Front Surg. 2022 Oct 4;9:879774. doi: 10.3389/fsurg.2022.879774.
37. Thulium fiber laser in endourology: current clinical evidence. Enikeev D, Herrmann TRW, Taratkin M, Azilgareeva C, Borodina A, Traxer O.Curr Opin Urol. 2023 Mar 1;33(2):95-107. doi: 10.1097/MOU.0000000000001057.
38. For Which Patients Should Bladder Preservation Be Considered After a Complete Response to Neoadjuvant Chemotherapy. Laukhtina E, Quhal F, von Deimling M, Kawada T, Yanagisawa T, Rajwa P, Majdoub M, Enikeev D, Shariat SF. Eur Urol Focus. 2023 May 5:S2405-4569(23)00106-2. doi: 10.1016/j.euf.2023.04.009.
39. Current Techniques for En Bloc Transurethral Resection of Bladder Tumor: A Hands-on Guide Through the Energy Landscape. Nicoletti R, Gauhar V, Castellani D, Enikeev D, Herrmann TRW, Teoh JY. Eur Urol Focus. 2023 May 11:S2405-4569(23)00104-9. doi: 10.1016/j.euf.2023.04.007
40. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. D'Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, Xylinas E, Lusuardi L, Heidenreich A, Cai C, Frego N, Taraktin M, Ryabov M, Gontero P, Compérat E, Shariat SF; eBLOC Study Team. Eur Urol Oncol. 2023 Aug 3:S2588-9311(23)00154-2. doi: 10.1016/j.euo.2023.07.010.
41. En bloc resection of bladder tumour: the rebirth of past through reminiscence. Teoh JY, D'Andrea D, Gallioli A, Yanagisawa T, MacLennan S, Nicoletti R, Fai NC, Maffei D, Hurle R, Lusuardi L, Malavaud B, Miki J, Kramer M, Mostafid H, Enikeev D, Babjuk M, Breda A, Shariat S, Gontero P, Herrmann T. World J Urol. 2023 Aug 16. doi: 10.1007/s00345-023-04547-0.

1. CRYOABLATION IN UROLOGY Glybochko P.V., Alyaev Yu.G., Amosov A.V., Enikeev D.V., Chinenov D.V., Lumpov I.S., Vorobiev A.A. Urologiya. 2014. No6. p. 108-112.
2. FOCAL LASER THERMOCOAGULATION FOR LOCALIZED PROSTATE CANCER Glybochko P.V., Vinarov A.Z., Shpot E.V., Sorokin N.I., Dymov A.N., Chinenov D.V., Enikeev D.V., Shmeleva E.A., Koshkarev A.V., Lumpov I.S. Urologiya. 2016. No4. p. 128-136
3. IRREVERSIBLE ELECTROPORATION TO TREAT PROSTATE CANCER (NANOKNIFE) Glybochko P.V., Alyaev Yu.G., Amosov A.V., Enikeev D.V., Chinenov D.V., Krupinov G.E., Chernov Ya.N., Tivtikyan A.S. Urologiya 2016. No6. p. 153-157
4. OUTCOMES OF CRYOABLATION VS EXTRAPERITONEOSCOPIC RADICAL PROSTATECTOMY FOR PROSTATE CANCER Chernov Ya.N., Rapoport L.M., Amosov A.V., Shpot E.V., Chinenov D.V., Sorokin N.I., Akopyan G.N., Enikeev D.V., Akopyan G.S., Kharchilava R.R. Meditsinsky Vestnik Bashkortostana. May-June 2017. No12(3). p. 69
5. ULTRASOUND-GUIDED PERCUTANEOUS CRYOABLATION FOR RENAL CANCER Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Amosov A.V., Alekseeva T.M., Enikeev M.E., Tsarichenko D.G., Chinenov D.V., Kozmin L.D., Dzhalaev Z.K., Taratkin M.S. Urologiya. 2017;3:68-73
6. PERCUTANEOUS US-GUIDED RENAL CRYOABLATION USING 3D MODELING. Rapoport LM, Cytron S, Enikeev ME, Tsarichenko DG, Enikeev DV, Chinenov DV. 2017 Aug 1;84(3):174-178. doi: 10.5301/uj.5000231. Epub 2017 May 10.
7. COMPARATIVE RESULTS OF CRYOABLATION AND LAPAROSCOPIC RADICAL PROSTATECTOMY IN THE TREATMENT OF LOCALIZED PROSTATE CANCER. Chinenov DV, Rapoport LM, Shpot EV, Enikeev DV, Chernov YN, Taratkin MS, Korolev DO. 2018 May;85(2):68-72. doi: 10.1177/0391560317749425. Epub 2018 Mar 25. PubMed PMID: 30043713.
8. FUTURE OF FOCAL THERAPY FOR THE TREATMENT OF PROSTATE CANCER- EUROPEAN SECTION OF UROTECHNOLOGY (ESUT) POSITION. Barret E, Ganzer R, Salomon G, Fielder M, Celia A, Enikeev D, Martínez-Salamanca JI, Liatsikos E, Gómez Rivas J. Arch Esp Urol. 2019 Mar;72(2):167-173.
9. A systematic review of irreversible electroporation in localised prostate cancer treatment. Morozov A, Taratkin M, Barret E, Singla N, Bezrukov E, Chinenov D, Enikeev M, Gomez Rivas J, Shpikina A, Enikeev D. 2020 Aug 12:e13789. doi: 10.1111/and.13789.
10. Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis. Enikeev D, Morozov A, Bazarkin A, Shpikina A, Brill B, Teoh JY, Suvorov A, Singla N, Taratkin M, Rivas JG, Barret E; ESUT Ablative Group. Minerva Urol Nephrol. 2023 Apr;75(2):154-162. doi: 10.23736/S2724-6051.22.05036-4.

1. FOCAL NEUROENDOCRINE DIFFERENTIATION OF CONVENTIONAL PROSTATE ADENOCARCINOMA AS A PROGNOSTIC FACTOR AFTER RADICAL PROSTATECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS. Kardoust Parizi M, Iwata T, Kimura S, Janisch F, Abufaraj M, Karakiewicz PI, Enikeev D, Rapoport LM, Hutterer G, Shariat SF. Int J Mol Sci. 2019 Mar 19;20(6). pii: E1374. doi: 10.3390/ijms20061374. Review.
2. ASSESSMENT OF BODY COMPOSITION IN THE ADVANCED STAGE OF CASTRATION-RESISTANT PROSTATE CANCER: SPECIAL FOCUS ON SARCOPENIA. Stangl-Kremser J, Suarez-Ibarrola R, Andrea D, Korn SM, Pones M, Kramer G, Marhold M, Krainer M, Enikeev DV, Glybochko PV, Tamandl D, Shariat SF, Baltzer P. Prostate Cancer Prostatic Dis. 2019 Nov 19. doi: 10.1038/s41391-019-0186-6. [Epub ahead of print] PubMed PMID: 31745255.
3. DETECTION OF MARKER MIRNAS, ASSOCIATED WITH PROSTATE CANCER, IN PLASMA USING SOI-NW BIOSENSOR IN DIRECT AND INVERSION MODES. Ivanov Y, Pleshakova T, Malsagova K, Kurbatov L, Popov V, Glukhov A, Smirnov A, Enikeev D, Potoldykova N, Alekseev B, Dolotkazin D, Kaprin A, Ziborov V, Petrov O, Archakov A. Sensors (Basel). 2019 Nov 29;19(23). pii: E5248. doi: 10.3390/s19235248. PubMed PMID:31795306.
4. EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN NON-METASTATIC PROSTATE CANCER. Kimura S, D'Andrea D, Iwata T, Foerster B, Janisch F, Parizi MK, Moschini M, Briganti A, Babjuk M, Chlosta P, Karakiewicz PI, Enikeev D, Rapoport LM, Seebacher V, Egawa S, Abufaraj M, Shariat SF. World J Urol. 2019 Dec 4. doi: 10.1007/s00345-019-03038-5. [Epub ahead of print] PubMed PMID:31797075.
5. PROGNOSTIC VALUE OF HEMOGLOBIN IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Janisch F, Mostafaei H, Lysenko I, Karakiewicz PI, Enikeev DV, Briganti A, Kimura S, Egawa S, Shariat SF. Clin Genitourin Cancer. 2019 Dec 13. pii: S1558-7673(19)30375-1. doi: 10.1016/j.clgc.2019.12.002. [Epub ahead of print] Review. PMID: 32007439
6. PROGNOSTIC VALUE OF LACTATE DEHYDROGENASE IN METASTATIC PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Kimura S, Parizi MK, Enikeev DV, Glybochko PV, Seebacher V, Fajkovic H, Mostafaei H, Lysenko I, Janisch F, Egawa S, Shariat SF. Clin Genitourin Cancer. 2019 Dec;17(6):409-418. doi: 10.1016/j.clgc.2019.07.009. Epub 2019 Jul 19. Review. PubMed PMID: 31558410.
7. DEVELOPMENT OF A PROGNOSTIC MODEL FOR SURVIVAL TIME PREDICTION IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS. Stangl-Kremser J, Mari A, Suarez-Ibarrola R, D'Andrea D, Korn SM, Pones M, Kramer G, Karakiewicz P, Enikeev DV, Glybochko PV, Briganti A, Shariat SF. Urol Oncol. 2020 Jan 14. pii: S1078-1439(19)30478-8. doi: 10.1016/j.urolonc.2019.11.005. [Epub ahead of print] PMID: 31953003
8. PROGNOSTIC VALUE OF ALKALINE PHOSPHATASE IN HORMONE-SENSITIVE PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Enikeev DV, Kimura S, Egawa S, Shariat SF. Int J Clin Oncol. 2020 Feb;25(2):247-257. doi: 10.1007/s10147-019-01578-9. Epub 2019 Nov 25. Review. PMID: 31768692
9. THE PROGNOSTIC IMPACT OF TUMOUR NSD2 EXPRESSION IN ADVANCED PROSTATE CANCER. Stangl-Kremser J, Lemberger U, Hassler MR, Garstka N, Grubmüller B, Haitel A, Enikeev DV, Glybochko PV, Kramer G, Susani M, Shariat SF. 2020 Mar 2:1-6. doi: 10.1080/1354750X.2020.1734861. [Epub ahead of print]. PMID: 32091270
10. PROGNOSTIC VALUE OF GLEASON SCORE AT POSITIVE SURGICAL MARGIN IN PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Lysenko I, Mori K, Mostafaei H, Enikeev DV, Karakiewicz PI, Briganti A, Quhal F, Janisch F, Shariat SF. Clin Genitourin Cancer. 2020 Mar 4. pii: S1558-7673(20)30045-8. doi: 10.1016/j.clgc.2020.02.011. [Epub ahead of print] Review. PMID: 32229268
11. PLASMA SARCOSINE MEASURED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY DISTINGUISHES PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATE CANCER FROM BENIGN PROSTATE HYPERPLASIA. Markin PA, Brito A, Moskaleva N, Fodor M, Lartsova EV, Shpot YV, Lerner YV, Mikhajlov VY, Potoldykova NV, Enikeev DV, Lyundup AV, Appolonova SA. Lab Med. 2020 Mar 12. pii: lmaa008. doi: 10.1093/labmed/lmaa008. [Epub ahead of print]. PMID: 32161964
12. THERE IS A NEED OF NOVEL RISK CLASSIFICATIONS IN PROSTATE CANCER. AN INVITED COMMENTARY ON 'REDUCED CANCER-SPECIFIC SURVIVAL OF LOW PROSTATE-SPECIFIC ANTIGEN IN HIGH-GRADE PROSTATE CANCER: A POPULATION-BASED RETROSPECTIVE COHORT STUDY'. Gómez Rivas J, Enikeev D. Int J Surg. 2020 Mar 12;77:61-62. doi: 10.1016/j.ijsu.2020.03.014. [Epub ahead of print] No abstract available. PMID: 32173613
13. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.  Markin PA, Brito A, Moskaleva N, Lartsova EV, Shpot YV, Lerner YV, Mikhajlov VY, Potoldykova NV, Enikeev DV, La Frano MR, Appolonova SA.  DOI: 10.1007/s11306-020-01694-y
14. The Risk of New Onset Dementia And/Or Alzheimer's Disease Among Prostate Cancer Patients Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-analysis.  Sari Motlagh R, Quhal F, Mori K, Miura N, Aydh A, Laukhtina E, Pradere B, Karakiewicz PI, Enikeev DV, Deuker M, Shariat SF.  Journal of Urology. DOI: 10.1097/JU.0000000000001341
15. Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes. Enikeev D, Morozov A,Taratkin M, Barret E, Kozlov V, Singla N, Rivas JG, Podoinitsin A, Margulis V, Glybochko P Clinical Genitourinary Cancer. DOI: 10.1016/j.clgc.2020.05.008
16. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics. Morozov A, Kozlov V, Rivas JG, Teoh JY, Bezrukov E, Amosov A, Barret E, Taratkin M, Salomon G, Herrmann TRW, Gozen A, Enikeev D; collaboration between ESUT, ESUI and Uro-technology WP of the Young Academic Urologists. World J Urol. 2021 Apr 7. doi: 10.1007/s00345-021-03684-8. Epub ahead of print.
17. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review. Laukhtina E, Sari Motlagh R, Mori K, Quhal F, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Ploussard G, Karakiewicz PI, Briganti A, Abufaraj M, Enikeev D, Pradere B, Shariat SF. World J Urol. 2021 May 28:1-15. doi: 10.1007/s00345-021-03703-8. 
18. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta- Analysis. Chan VW, Tan WS, Asif A, Ng A, Gbolahan O, Dinneen E, To W, Kadhim H, Premchand M, Burton O, Koe JS, Wang N, Leow JJ, Giannarini G, Vasdev N, Shariat SF, Enikeev D, Ng CF, Teoh JY. Cancers (Basel). 2021 Jun 30;13(13):3274. doi: 10.3390/cancers13133274.
19. A systematic review of nerve-sparing surgery for high-risk prostate cancer. Morozov A, Barret E, Veneziano D, Grigoryan V, Salomon G, Fokin I, Taratkin M, Poddubskaya E, Gomez Rivas J, Puliatti S, Okhunov Z, Cacciamani GE, Checcucci E, Marenco Jiménez JL, Enikeev D; ESUT-YAUWP Group. Minerva Urol Nephrol. 2021 Jun;73(3):283-291. doi: 10.23736/S2724-6051.20.04178-8. Epub 2021 Jan 13. PMID: 33439578.
20. The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review. Gómez Rivas J, Carrion DM, Chandrasekar T, Álvarez-Maestro M, Enikeev D, Martínez-Piñeiro L, Barret E. Actas Urol Esp (Engl Ed). 2021 Apr;45(3):188-197. English, Spanish. doi: 10.1016/j.acuro.2020.04.011. Epub 2020 Nov 11. PMID: 33189417.
21. The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials Sari Motlagh R, Abufaraj M, Mori K, Aydh A, Rajwa P, Katayama S, Grossmann NC, Laukhtina E, Mostafai H, Pradere B, Quhal F, Karakiewicz PI, Enikeev DV, Shariat SF. Eur Urol Oncol. 2021 Jul 20:S2588-9311(21)00122-X. doi: 10.1016/j.euo.2021.07.002. Epub ahead of print. PMID: 34301529.
22. Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy. Aydh A, Mori K, D'Andrea D, Motlagh RS, Abufaraj M, Pradere B, Mostafaei H, Laukhtina E, Quhal F, Karakiewicz PI, Luzzago S, Briganti A, Trinh QD, Parizi MK, Tilki D, Enikeev DV, Shariat SF. Int J Clin Oncol. 2021 Sep;26(9):1729-1735. doi: 10.1007/s10147-021-01952-6. Epub 2021 Jun 28. PMID: 34184136; PMCID: PMC8364901.
23. Isolation of Circulating Tumor Cells from Seminal Fluid of Patients with Prostate Cancer Using Inertial Microfluidics. Rzhevskiy AS, Kapitannikova AY, Vasilescu SA, Karashaeva TA, Razavi Bazaz S, Taratkin MS, Enikeev DV, Lekarev VY, Shpot EV, Butnaru DV, Deyev SM, Thiery JP, Zvyagin AV, Ebrahimi Warkiani M. Cancers (Basel). 2022 Jul 11;14(14):3364. doi: 10.3390/cancers14143364. PMID: 35884424;
24. A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis. Enikeev D, Morozov A, Babaevskaya D, Bazarkin A, Malavaud B. Cancers (Basel). 2022 Aug 4;14(15):3802. doi: 10.3390/cancers14153802. PMID: 35954464;
25. Prospective comparison of cognitive and mpMR/US fusion biopsy for prostate cancer detection. Petov VS, Bazarkin AK, Morozov AO, Taratkin MS, Ganzha TM, Danilov SP, Chernov YN, Chinenov DV, Amosov AV, Enikeev DV, Krupinov GE. 2022 Sep;(4):38-43. Russian. PMID: 36098588.
26. Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis. Petov V, Azilgareeva C, Shpikina A, Morozov A, Krupinov G, Kozlov V, Singla N, Gómez Rivas J, Jesús MS, Puliatti S, Checcucci E, Rodler S, Belenchon IR, Kowalewski KF, Veccia A, Mcfarland J, Cacciamani GE, Taratkin M, Enikeev D.
27. Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking. Huang J, Chan EO, Liu X, Lok V, Ngai CH, Zhang L, Xu W, Zheng ZJ, Chiu PK, Vasdev N, Enikeev D, Shariat SF, Ng CF, Teoh JY, Wong MCS. Clin Genitourin Cancer. 2023 Feb 15:S1558-7673(23)00036-8. doi: 10.1016/j.clgc.2023.02.003.
28. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading. Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D; Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology. Prostate Cancer Prostatic Dis. 2023 Apr 25. doi: 10.1038/s41391-023-00673-3.
29. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection. Petov V, Bazarkin A, Morozov A, Taratkin M, Ganzha T, Danilov S, Chernov Y, Chinenov D, Rzayev R, Suvorov A, Amosov A, Fajkovic H, Enikeev D, Krupinov G. J Endourol. 2023 Aug;37(8):940-947. doi: 10.1089/end.2022.0780.

1. HOLMIUM LASER ENUCLEATION OF LARGE PROSTATE HYPERPLASIA (HOLEP) - AN ALTERNATIVE TO OPEN SIMPLE PROSTATECTOMY. Enikeev M.E., Sorokin N.I., Enikeev D.V., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Davydov D.S. Medical Bulletin of Bashkortostan. 2015. V. 10. No. 3. S. 249-251.

2. TREATMENT OF PATIENTS WITH BENIGN PROSTATE HYPERPLASIA USING HOLMIUM LASER ENUCLEATION (HOLEP) AT THE STAGE OF MASTERING THE METHOD. Sorokin N.I., Enikeev D.V., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Davydov D.S. Medical Bulletin of Bashkortostan [RUS]. 2015. V. 10. No. 3. S. 238-240.

3. HOLMIUM LASER ENUCLEATION OF PROSTATE HYPERPLASIA: TECHNICAL ASPECTS. Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Enikeev M.E., Enikeev D.V., Sorokin N.I., Sukhanov R.B. , Dymov A.M., Khamraev O.Kh., Davydov D.S., Taratkin M.S. Andrology and genital surgery[RUS]. 2015. V. 16. No. 4. S. 55-59.

4. HOLMIUM LASER ENUCLEATION (HOLEP) FOR PROSTATE HYPERPLASIA OF SMALL, LARGE AND GIANT SIZES. PRACTICAL RECOMMENDATIONS. EXPERIENCE OF MORE THAN 450 PROCEDURES. D.V. Enikeev, P.V. Glybochko, Yu.G. Alyaev, L.M. Rapoport, M.E. Enikeev, D.G. Tsarichenko, N.I. Sorokin, R.B. Sukhanov, A.M. Dymov, O.Kh. Khamraev, D.S. Davydov, M.S. Taratkin, R.R. Simberdeev. Urology[RUS]. 2016. No. 4. S. 63-69.

5. TRANSURETRAL MONOPOLAR ENUCLEATION OF BENIGN PROSTATE HYPERPLASIA. OUR EXPERIENCE Tsarichenko, R.R. Simberdeev, P.V. Glybochko, Yu.G. Alyaev, L.M. Rapoport, R.B. Sukhanov, N.I. Sorokin, D.V. Enikeev, D.S. Davydov. Urology[RUS]. 2016. No. 4. P. 70-75.

6. HOLMIUM LASER ENUCLEATION OF PROSTATE HYPERPLASIA: A TWO-YEAR EXPERIENCE. Davydov, A.Z. Vinarov, D.G. Tsarichenko, E.A. Bezrukov, N.I. Sorokin, A.M. Dymov, D.V. Enikeev, R.B. Sukhanov. Medical Bulletin of Bashkortostan, Scientific and Practical Journal[RUS], Volume 12, No 3 (69) May-June 2017.

7. MODERN LASER TECHNOLOGIES IN SURGICAL TREATMENT OF PROSTATE HYPERPLASIA. D.V. Enikeev, P.V. Glybochko, Yu.G. Alyaev, L.M. Rapoport, A.Z. Vinarov, M.E. Enikeev, N.I. Sorokin, L.G. Spivak, R.B. Sukhanov, A.M. Dymov, O.Kh. Khamraev, M.S. Taratkin, V.A. Vinnichenko. Urology[RUS]. 2017. No. 1. P. 108-113.

8. LASER ENUCLEATION OF PROSTATE HYPERPLASIA (HOLEP AND THULEP): COMPARATIVE ANALYSIS OF EFFICACY IN THE TREATMENT OF RECURRENT PROSTATE HYPERPLASIA. D.V. Enikeev, P.V. Glybochko, Yu.G. Alyaev, L.M. Rapoport, N.I. Sorokin, M.E. Enikeev, A.M. Dymov, R.B.Sukhanov, O.Kh.Khamraev, M.S.Taratkin, A.V.Dymova, Zh.Sh.Inoyatov. Urology[RUS].2017;4:50-55.

9. ENDOSCOPIC PROSTATE ENUCLEATION IS A NEW STANDARD FOR SURGICAL TREATMENT OF PROSTATE HYPERPLASIA. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Enikeev M.E., Spivak L.G., Tsarichenko D.G., Sorokin N.I., Sukhanov R. B., Dymov A.M., Khamraev O.Kh., Gaas M.Ya., Taratkin M.S. Andrology and genital surgery[RUS]. 2017;18(3):83-88.

10. COMPARATIVE ANALYSIS OF THE EFFICACY OF VARIOUS METHODS OF ENDOSCOPIC ENUCLEATION OF THE PROSTATE. D. V. Enikeev, P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, N. I. Sorokin, R. B. Sukhanov, L. T. O. Kh. Khamraev, M. S. Taratkin, E. A. Laukhtina Surgery.  Journal named by N.I. Pirogov[RUS]. 2017;(11): 4-14, DOI:10.17116/hirurgia2017114-14.

11. HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) FOR SMALL, LARGE AND GIANT PROSTATIC HYPERPLASIA: TIPS AND TRICKS. Glybochko PV, Rapoport LM, Enikeev ME, Enikeev DV. 2017 Aug 1;84(3):169-173. doi: 10.5301/uj.5000232. Epub 2017 May 10.

12. RETROSPECTIVE ANALYSIS OF SHORT-TERM OUTCOMES AFTER MONOPOLAR VERSUS LASER ENDOSCOPIC ENUCLEATION OF THE PROSTATE: A SINGLE CENTER EXPERIENCE. Enikeev D, Glybochko P, Okhunov Z, Alyaev Y, Rapoport L, Tsarichenko D, Enikeev M, Sorokin N, Dymov A, Taratkin M. J Endourol. 2018 May; 32(5):417-423. doi: 10.1089/end.2017.0898. Epub 2018 Mar 13.

13. NEED FOR UPPER URINARY TRACT STENTING IN CASES OF URETERAL ORIFICE INJURY DURING LASER ENUCLEATION OF THE PROSTATE. Enikeev D, Glybochko P, Rapoport L, Snurnitsyna O, Potoldykova N, Novoselova T, Laukhtina E, Taratkin M, Margulis V. Int Urol Nephrol. 2018 Oct 22. doi: 10.1007/s11255-018-2007-6. [Epub ahead of print] PubMed PMID: 30349963.

14. IMPACT OF ENDOSCOPIC ENUCLEATION OF THE PROSTATE WITH THULIUM FIBER LASER ON THE ERECTILE FUNCTION. Enikeev D, Glybochko P, Rapoport L, Okhunov Z, O'Leary M, Potoldykova N, Sukhanov R, Enikeev M, Laukhtina E, Taratkin M. BMC Urol. 2018 Oct 12;18(1):87. doi: 10.1186/s12894-018-0400-1. PubMed PMID: 30314492; PubMed.

15. A RANDOMIZED TRIAL COMPARING THE LEARNING CURVE OF THREE ENDOSCOPIC ENUCLEATION TECHNIQUES (HOLEP, THUFLEP AND MEP) FOR BPH USING MENTORING APPROACH - INITIAL RESULTS. Enikeev D, Glybochko P, Rapoport L, Gahan J, Gazimiev M, Spivak L, Enikeev M, Taratkin M. 2018 Jul 24. pii: S0090-4295(18)30763-5. doi: 10.1016/j.urology.2018.06.045. [Epub ahead of print] PubMed PMID: 30053397.

16. A FEASIBILITY STUDY UTILIZING THE THULIUM AND HOLMIUM LASER IN PATIENTS FOR THE TREATMENT OF RECURRENT BENIGN PROSTATIC HYPERPLASIA AFTER PREVIOUS PROSTATIC SURGERY. Becker B, Netsch C, Glybochko P, Rapoport L, Taratkin M, Enikeev D.

17. RESPONSE TO THE LETTER TO EDITOR: NEED FOR UPPER URINARY TRACT STENTING IN CASES OF URETERAL ORIFICE INJURY DURING LASER ENUCLEATION OF THE PROSTATE. Enikeev D. Int Urol Nephrol. 2019 Jun;51(6):969. doi: 10.1007/s11255-018-02069-y. Epub 2019 Apr 12.

18. EN BLOC AND TWO-LOBE TECHNIQUES FOR LASER ENDOSCOPIC ENUCLEATION OF THE PROSTATE: RETROSPECTIVE COMPARATIVE ANALYSIS OF PERI- AND POSTOPERATIVE OUTCOMES. Enikeev D, Taratkin M, Laukhtina E, Alekseeva T, Snurnitsyna O, Potoldykova N, Gerasimov A, Glybochko P. Int Urol Nephrol. 2019 Nov;51(11):1969-1974. doi: 10.1007/s11255-019-02259-2. Epub 2019 Aug 20. PubMed PMID: 31432393.

19. NOVEL THULIUM FIBER LASER FOR ENDOSCOPIC ENUCLEATION OF THE PROSTATE: A PROSPECTIVE COMPARISON WITH CONVENTIONAL TRANSURETHRAL RESECTION OF THE PROSTATE. Enikeev D, Netsch C, Rapoport L, Gazimiev M, Laukhtina E, Snurnitsyna O, Alekseeva T, Becker B, Taratkin M, Glybochko P. Int J Urol. 2019 Dec;26(12):1138-1143. doi: 10.1111/iju.14115. Epub 2019 Sep 22. PubMed PMID: 31544290.

20. MONOPOLAR ENUCLEATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE FOR SMALL- AND MEDIUM-SIZED (< 80 CC) BENIGN PROSTATE HYPERPLASIA: A PROSPECTIVE ANALYSIS. Enikeev D, Rapoport L, Gazimiev M, Allenov S, Inoyatov J, Taratkin M, Laukhtina E, Sung JM, Okhunov Z, Glybochko P. World J Urol. 2020 Jan;38(1):167-173. doi: 10.1007/s00345-019-02757-z. Epub 2019 Apr 8. PMID: 30963229

21. RETROSPECTIVE ASSESSMENT OF ENDOSCOPIC ENUCLEATION OF PROSTATE COMPLICATIONS: A SINGLE-CENTER EXPERIENCE OF MORE THAN 1400 PATIENTS. Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M, Afyouni AS, Okhunov Z, Glybochko P, Enikeev D. J Endourol. 2020 Feb;34(2):192-197. doi: 10.1089/end.2019.0630. PMID: 31810402

22. Long-Term Outcomes of Holmium Laser Enucleation of the Prostate: A 5-Year Single-Center Experience. Enikeev D, Taratkin M, Morozov A, Singla N, Gabdulina S, Tarasov A,Sukhanov R, Rivas JG, Laukhtina E, Arshiev M, Mikhailov V, Glybochko P.  Journal of Endourology. DOI: 10.1089/end.2020.0347

23. Systematic review of the endoscopic enucleation of the prostate learning curve. Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A, Gabdullina S, Herrmann TRW. World J Urol.2020 Sep 17. doi: 10.1007/s00345-020-03451-1. Epub ahead of print.

24. Re: Thulium Laser Transurethral Vaporesection of the Prostate Versus Transurethral Resection of the Prostate for Men with Lower Urinary Tract Symptoms or Urinary Retention (UNBLOCS): A Randomized Controlled Trial. Enikeev D, Taratkin M, Glybochko P. Eur Urol.2020 Sep 18:S0302-2838(20)30702-8. doi: 10.1016/j.eururo.2020.09.011.

25. Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis. Cheng BK, Castellani D, Chan IS, Baker A, Gauhar V, Wroclawski ML, Santamaria HT, Tanidir Y, Enikeev D, Chan VW, Ng CF, Herrmann T, Teoh JY. World J Urol. 2021 Jun 17. doi: 10.1007/s00345-021-03756-9. Epub ahead of print.

26. Postoperative medical treatment of lower urinary tract symptoms after benign prostatic hyperplasia surgery. Are we underestimating the problem? Spivak L, Morozov A, Shpikina A, Enikeev D, Rapoport L. Curr Opin Urol. 2021 Jun 25. doi: 10.1097/MOU.0000000000000912. Epub ahead of print. PMID: 34175875.

27. Laser endoscopic procedures on the prostate: it is the small details that count. Taratkin M, Azilgareeva C, Taratkina D, Goryacheva E, Rapoport L, Enikeev D. Curr Opin Urol. 2021 Jul 6. doi: 10.1097/MOU.0000000000000919. Epub ahead of print.

28. Reasons to go for thulium-based anatomical endoscopic enucleation of the prostate. Becker B, Netsch C, Bozzini G, Herrmann TRW, Bach T, Enikeev D, Gross AJ. World J Urol. 2021 Jul;39(7):2363-2374. doi: 10.1007/s00345-021-03704-7. Epub 2021 May 4. PMID: 33948694.

29. EAU, AUA and NICE Guidelines on Surgical and Minimally Invasive Treatment of Benign Prostate Hyperplasia: A Critical Appraisal of the Guidelines Using the AGREE-II Tool. Enikeev D, Misrai V, Rijo E, Sukhanov R, Chinenov D, Gazimiev M, Taratkin M, Azilgareeva C, Morozov A, Herrmann TRW, Glybochko P. Urol Int. 2021 Jul 28:1-10. doi: 10.1159/000517675. Epub ahead of print. PMID: 34350885.

30. Enucleation vs vaporization of benign prostatic hyperplasia: a head-to-head comparison of the various outcomes and complications. A systematic review and meta-analysis Taratkin M, Shpikina A, Morozov A, Novikov A, Fokin I, Petov V, Rw Herrmann T, Misrai V, Lusuardi L, Teoh JY, McFARLAND J, Kozlov V, Enikeev D.. Minerva Urol Nephrol. 2021 Nov 18. doi: 10.23736/S2724-6051.21.04639-5. Epub ahead of print. PMID: 34791865.

31. Ex vivo study of Ho:YAG and thulium fiber lasers for soft tissue surgery: which laser for which case? Taratkin M, Kovalenko A, Laukhtina E, Paramonova N, Spivak L, Wachtendorf LJ, Eminovic S, Afyouni AS, Okhunov Z, Karagezyan M, Mikhailov V, Strakhov Y, Herrmann TR, Enikeev D. Lasers Med Sci. 2022 Feb;37(1):149-154. doi: 10.1007/s10103-020-03189-7. PMID: 33175250.

32. Does Endoscopic Enucleation of the Prostate Need New Lasers? Current Perspective on New Laser Devices. Taratkin M, Enikeev D. Eur Urol Focus. 2022 Mar;8(2):394-395. doi: 10.1016/j.euf.2022.04.002. PMID: 35437230.

33. Randomized prospective trial of the severity of irritative symptoms after HoLEP vs ThuFLEP. Enikeev D, Taratkin M, Babaevskaya D, Morozov A, Petov V, Sukhanov R, Shpot E, Misrai V, Chinenov D, Enikeev M, Herrmann T. World J Urol. 2022 Aug;40(8):2047-2053. doi: 10.1007/s00345-022-04046-8. PMID: 35690952.

34. Thulium Fiber Laser Enucleation of the Prostate: Prospective Study of Mid- and Long-Term Outcomes in 1328 Patients. Petov V, Babaevskaya D, Taratkin M, Chuvalov L, Lusuardi L, Misrai V, Sukhanov R, Scoffone CM, Enikeev D. J Endourol. 2022 Sep;36(9):1231-1236. doi: 10.1089/end.2022.0029. PMID: 35414204.

35. Thulium Fiber Laser Enucleation of the Prostate: Prospective Study of Mid- and Long-Term Outcomes in 1328 Patients. Petov V, Babaevskaya D, Taratkin M, Chuvalov L, Lusuardi L, Misrai V, Sukhanov R, Scoffone CM, Enikeev D. J Endourol. 2022 Sep;36(9):1231-1236. doi: 10.1089/end.2022.0029. PMID: 35414204.

36. Comparison Between Thulium Fiber Laser and High-power Holmium Laser for Anatomic Endoscopic Enucleation of the Prostate: A Propensity Score-matched Analysis from the REAP Registry. Gauhar V, Nedbal C, Castellani D, Fong KY, Sofer M, Socarrás MR, Tursunkulov AN, Ying LK, Elterman D, Mahajan A, Petov V, Ivanovich SN, Bhatia TP, Enikeev D, Gadzhiev N, Chiruvella M, Teoh JY, Galosi AB, Sancha FG, Somani BK, Herrmann TRW. Eur Urol Focus. 2023 Jul 4:S2405-4569(23)00150-5. doi: 10.1016/j.euf.2023.06.009.

37. Holmium laser with MOSES technology (MoLEP) vs Thulium fiber laser enucleation of the prostate (ThuFLEP) in a real-world setting. Mid- term outcomes from a multicenter propensity score analysis. Castellani D, Di Rosa M, Gómez Sancha F, Rodríguez Socarrás M, Mahajan A, Taif Bendigeri M, Taratkin M, Enikeev D, Dellabella M, Gadzhiev N, Somani BK, Herrmann TRW, Gauhar V. World J Urol. 2023 Jul 29. doi: 10.1007/s00345-023-04524-7. Epub ahead of print. PMID: 37515650.

38. Experts' recommendations in laser use for the endoscopic treatment of prostate hypertrophy: a comprehensive guide by the European Section of Uro- Technology (ESUT) and Training-Research in Urological Surgery and Technology (T.R.U.S.T.)-Group. Ortner G, Güven S, Somani BK, Nicklas A, Scoffone CM, Gracco C, Goumas IK, Bach T, Sancha FG, Figueredo FCA, Krambeck A, Bozzini G, Lehrich K, Liatsikos E, Kallidonis P, Roche JB, Miernik A, Enikeev D, Tunc L, Bhojani N, Gilling P, Otero JR, Porreca A, Ahyai S, Netsch C, Gözen AS, Nagele U, Herrmann TRW, Tokas T. World J Urol. 2023 Aug 26. doi: 10.1007/s00345-023-04565-y.

Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety (New surgical techniques)

Urology

Principal Investigator

2018 - 2020

ThuLEP vs.HoLEP vs. Monopolar Enucleation in Management of BPH (New surgical techniques)

Urology

Principal Investigator

2016 - 2017

Double-Blind Multicenter Randomized Phase III trial to Evaluate the Efficacy and Safety of Plasomycin vs Meropenem with Subsequent Potential Systemic per os Treatment for Infections of the Urinary Tract (including Acute Pyelonephritis) Associated with Complications in Adult Patients

Urology, Nephrology

Co-investigator

2015 – 2017

A Randomized Phase III Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Cisplatin-Ineligible Participants with Muscle-Invasive Bladder Cancer (KEYNOTE-905/EV-303)

Urology, Oncology

Principal Investigator

2021 - present

A Phase III Randomized Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoajuvant Gemcitabine and Cisplatin in Cisplatin-Eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-B15 / EV-304)

Principal Investigator

2021 - present

A Randomized Controlled Multicenter Open-Label Study to Investigate the Efficacy and Safety of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients with PSMA-PET-Positive Hormone-Sensitive Prostate Cancer, with Active Surveillance for PSMA-PET-Negative Prostate Cancer

Urology, Oncology

Co-investigator

2021- present

A Phase III Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Select FGFR Gene Aberrations

Urology, Oncology

Co-investigator

2021 - present

A Phase III Randomized Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer (CheckMate 7DX: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 7DX)

Urology, Oncology

Co-investigator

2021- present

An Open-Label Randomized Phase III Study of MK-6482 versus Everolimus in Participants with Advanced Progressing Renal Cell Carcinoma after Prior PD-1/L1 and VEGF-Targeted Therapies

Urology, Oncology

Principal Investigator

2020 - present

Randomized Double-Blind Multicenter Phase III Clinical Trial with Active Control to Evaluate the Efficacy and Safety of a Combination of Lenvatinib (Drug E7080/MK-7902) and Pembrolizumab (Drug MK-3475) vs Lenvatinib as First-Line Treatment in Patients with Metastatic Hepatocellular Carcinoma (LEAP-002)

Oncology

Co-investigator

2019 - present

Efficacy and Safety Assessment of IRE of Localized Prostate Cancer (New surgical techniques)

Urologic Oncology

Principal Investigator

2016 - 2017

Thulium Fiber Laser en bloc Resection vs Conventional Transurethral Resection of Non -Muscle-Invasive Bladder Cancer (New surgical techniques)

Urologic Oncology

Principal Investigator

2015 - 2018

Randomized Double-Blind Placebo-Controlled Multicenter Phase II Trial to Evaluate the Efficacy, Tolerability and Safety of Olaparib vs Placebo as Adjuvant Therapy in Patients on Abiraterone with Metastatic Castration-Resistant Prostate Cancer who Received prior Chemotherapy with Docetaxel

Oncology

Co-investigator

2014 - 2020

A Randomized Double-Blind Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of Masitinib Combined with Isoquercetin and Best Supportive Care in Hospitalized Patients with Moderate and Severe COVID-19

AB20001 – AB Science

Principal Investigator

2021 - present

1. HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) FOR LARGE PROSTATIC HYPERPLASIA. AN ALTERNATIVE TO OPEN ADENECTOMY. Enikeev M.E., Sorokin N.I., Enikeev D.V., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Davydov D.S. Meditsinsky Vestnik Bashkortostana. 2015. No10(3). p. 249-251.
2. OUTCOMES OF HOLMIUM LASER ENUCLEATION (HOLEP) FOR BENIGN PROSTATIC HYPERPLASIA: LEARNING THE TECHNIQUE. Sorokin N.I., Enikeev D.V., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Davydov D.S. Meditsinsky Vestnik Bashkortostana. 2015. No10(3). p. 238-240. 
3. HOLMIUM LASER ENUCLEATION OF PROSTATIC HYPERPLASIA: TECHNICAL ASPECTS. Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Enikeev M.E., Enikeev D.V., Sorokin N.I., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Davydov D.S., Taratkin M.S. Andrologiya i genitalnaya khirurgiya. 2015. No16(4). p. 55-59.
4. HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) FOR SMALL, LARGE AND GIANT PROSTATIC HYPERPLASIA. PRACTICE GUIDELINES. EXPERIENCE OF MORE THAN 450 SURGERIES. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Enikeev M.E., Tsarichenko D.G., Sorokin N.I., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Davydov D.S., Taratkin M.S., Simberdeev R.R. Urologiya. 2016. No4. p. 63-69.
5. TRANSURETHRAL MONOPOLAR ENUCLEATION FOR BENIGN PROSTATIC HYPERPLASIA. OUR EXPERIENCE. Tsarichenko D.G., Simberdeev R.R., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Sukhanov R.B., Sorokin N.I., Enikeev D.V., Davydov D.S. Urologiya. 2016. No4. p. 70-75
6. HOLMIUM LASER ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA: TWO-YEAR EXPERIENCE. Davydov D.S., Vinarov A.Z., Tsarichenko D.G., Bezrukov E.A., Sorokin N.I., Dymov A.M., Enikeev D.V., Sukhanov R.B. Meditsinsky Vestnik Bashkortostana. May-June 2017. No12(3). p. 69.
7. MODERN LASER TECHNOLOGIES FOR SURGICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Vinarov A.Z., Enikeev M.E., Sorokin N.I., Spivak L.G., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Taratkin M.S., Vinnichenko V.A. Urologiya. 2017. No1. p. 108-113
8. EFFICACY OF LASER ENUCLEATION FOR RECURRENT PROSTATIC HYPERPLASIA (HOLEP AND THULEP): A COMPARATIVE ANALYSIS. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Sorokin N.I., Enikeev M.E., Dymov A.M., Sukhanov R.B., Khamraev O. Kh., Taratkin M.S., Dymova A.V., Inoyatov Zh.Sh. Urologiya. 2017;4:50-55
9. ENDOSCOPIC ENUCLEATION OF THE PROSTATE – A NEW STANDARD IN SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Enikeev M.E., Spivak L.G., Tsarichenko D.G., Sorokin N.I., Sukhanov R.B., Dymov A.M., Khamraev O.Kh., Gaas M.Ya., Taratkin M.S. Andrologiya i genitalnaya khirurgiya. 2017;18(3):83-88.
10. A COMPARATIVE ANALYSIS OF ENDOSCOPIC ENUCLEATION TECHNIQUES FOR PROSTATIC HYPERPLASIA. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Sorokin N.I., Sukhanov R.B., Spivak L.T., Khamraev O.Kh., Taratkin M.S., Laukhtina E.A. Khirurgiya. Zhurnal imeni N.I. Pirogova. 2017;(11): 4-14, DOI:10.17116/hirurgia2017114-14 
11. HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) FOR SMALL, LARGE AND GIANT PROSTATIC HYPERPLASIA: TIPS AND TRICKS. Glybochko PV, Rapoport LM, Enikeev ME, Enikeev DV. Urologia. 2017 Aug 1;84(3):169-173. doi: 10.5301/uj.5000232. Epub 2017 May 10. 
12. RETROSPECTIVE ANALYSIS OF SHORT-TERM OUTCOMES AFTER MONOPOLAR VERSUS LASER ENDOSCOPIC ENUCLEATION OF THE PROSTATE: A SINGLE CENTER EXPERIENCE. Enikeev D, Glybochko P, Okhunov Z, Alyaev Y, Rapoport L, Tsarichenko D, Enikeev M, Sorokin N, Dymov A, Taratkin M. J Endourol. 2018 May; 32(5):417-423. doi: 10.1089/end.2017.0898. Epub 2018 Mar 13. 
13. NEED FOR UPPER URINARY TRACT STENTING IN CASES OF URETERAL ORIFICE INJURY DURING LASER ENUCLEATION OF THE PROSTATE. Enikeev D, Glybochko P, Rapoport L, Snurnitsyna O, Potoldykova N, Novoselova T, Laukhtina E, Taratkin M, Margulis V. Int Urol Nephrol. 2018 Oct 22. doi: 10.1007/s11255-018-2007-6. [Epub ahead of print] PubMed PMID: 30349963. 
14. IMPACT OF ENDOSCOPIC ENUCLEATION OF THE PROSTATE WITH THULIUM FIBER LASER ON THE ERECTILE FUNCTION. Enikeev D, Glybochko P, Rapoport L, Okhunov Z, O'Leary M, Potoldykova N, Sukhanov R, Enikeev M, Laukhtina E, Taratkin M. BMC Urol. 2018 Oct 12;18(1):87. doi: 10.1186/s12894-018-0400-1. PubMed PMID: 30314492; PubMed.  
15. A RANDOMIZED TRIAL COMPARING THE LEARNING CURVE OF THREE ENDOSCOPIC ENUCLEATION TECHNIQUES (HOLEP, THUFLEP AND MEP) FOR BPH USING MENTORING APPROACH - INITIAL RESULTS. Enikeev D, Glybochko P, Rapoport L, Gahan J, Gazimiev M, Spivak L, Enikeev M, Taratkin M. Urology. 2018 Jul 24. pii: S0090-4295(18)30763-5. doi: 10.1016/j.urology.2018.06.045. [Epub ahead of print] PubMed PMID: 30053397. 
16. A FEASIBILITY STUDY UTILIZING THE THULIUM AND HOLMIUM LASER IN PATIENTS FOR THE TREATMENT OF RECURRENT BENIGN PROSTATIC HYPERPLASIA AFTER PREVIOUS PROSTATIC SURGERY. Becker B, Netsch C, Glybochko P, Rapoport L, Taratkin M, Enikeev D. 
17. NOVEL THULIUM FIBER LASER FOR ENUCLEATION OF PROSTATE: A RETROSPECTIVE COMPARISON WITH OPEN SIMPLE PROSTATECTOMY. Enikeev D, Okhunov Z, Rapoport L, Taratkin M, Enikeev M, Snurnitsyna O, Capretz T, Inoyatov J, Glybochko P. J Endourol. 2019 Jan;33(1):16-21. doi: 10.1089/end.2018.0791. 
18. RESPONSE TO THE LETTER TO EDITOR: NEED FOR UPPER URINARY TRACT STENTING IN CASES OF URETERAL ORIFICE INJURY DURING LASER ENUCLEATION OF THE PROSTATE. Enikeev D. Int Urol Nephrol. 2019 Jun;51(6):969. doi: 10.1007/s11255-018-02069-y. Epub 2019 Apr 12. 
19. N BLOC AND TWO-LOBE TECHNIQUES FOR LASER ENDOSCOPIC ENUCLEATION OF THE PROSTATE: RETROSPECTIVE COMPARATIVE ANALYSIS OF PERI- AND POSTOPERATIVE OUTCOMES. Enikeev D, Taratkin M, Laukhtina E, Alekseeva T, Snurnitsyna O, Potoldykova N, Gerasimov A, Glybochko P. Int Urol Nephrol. 2019 Nov;51(11):1969-1974. doi: 10.1007/s11255-019-02259-2. Epub 2019 Aug 20. PubMed PMID: 31432393. 
20. NOVEL THULIUM FIBER LASER FOR ENDOSCOPIC ENUCLEATION OF THE PROSTATE: A PROSPECTIVE COMPARISON WITH CONVENTIONAL TRANSURETHRAL RESECTION OF THE PROSTATE. Enikeev D, Netsch C, Rapoport L, Gazimiev M, Laukhtina E, Snurnitsyna O, Alekseeva T, Becker B, Taratkin M, Glybochko P. Int J Urol. 2019 Dec;26(12):1138-1143. doi: 10.1111/iju.14115. Epub 2019 Sep 22. PubMed PMID: 31544290. 
21. MONOPOLAR ENUCLEATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE FOR SMALL- AND MEDIUM-SIZED (< 80 CC) BENIGN PROSTATE HYPERPLASIA: A PROSPECTIVE ANALYSIS. Enikeev D, Rapoport L, Gazimiev M, Allenov S, Inoyatov J, Taratkin M, Laukhtina E, Sung JM, Okhunov Z, Glybochko P. World J Urol. 2020 Jan;38(1):167-173. doi: 10.1007/s00345-019-02757-z. Epub 2019 Apr 8. PMID: 30963229. 
22. RETROSPECTIVE ASSESSMENT OF ENDOSCOPIC ENUCLEATION OF PROSTATE COMPLICATIONS: A SINGLE-CENTER EXPERIENCE OF MORE THAN 1400 PATIENTS. Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M, Afyouni AS, Okhunov Z, Glybochko P, Enikeev D. J Endourol. 2020 Feb;34(2):192-197. doi: 10.1089/end.2019.0630. PMID: 31810402. 
23. Long-Term Outcomes of Holmium Laser Enucleation of the Prostate: A 5-Year Single-Center Experience. Enikeev D, Taratkin M, Morozov A, Singla N, Gabdulina S, Tarasov A,Sukhanov R, Rivas JG, Laukhtina E, Arshiev M, Mikhailov V, Glybochko P. Journal of Endourology. DOI: 10.1089/end.2020.0347. 
24. Systematic review of the endoscopic enucleation of the prostate learning curve. Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A, Gabdullina S, Herrmann TRW. World J Urol. 2020 Sep 17. doi: 10.1007/s00345-020-03451-1. Epub ahead of print.  
25. Re: Thulium Laser Transurethral Vaporesection of the Prostate Versus Transurethral Resection of the Prostate for Men with Lower Urinary Tract Symptoms or Urinary Retention (UNBLOCS): A Randomized Controlled Trial. Enikeev D, Taratkin M, Glybochko P. Eur Urol. 2020 Sep 18:S0302-2838(20)30702-8. doi: 10.1016/j.eururo.2020.09.011. 
26. Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis. Cheng BK, Castellani D, Chan IS, Baker A, Gauhar V, Wroclawski ML, Santamaria HT, Tanidir Y, Enikeev D, Chan VW, Ng CF, Herrmann T, Teoh JY. World J Urol. 2021 Jun 17. doi: 10.1007/s00345-021-03756-9. Epub ahead of print. 
27. Postoperative medical treatment of lower urinary tract symptoms after benign prostatic hyperplasia surgery. Are we underestimating the problem? Spivak L, Morozov A, Shpikina A, Enikeev D, Rapoport L. Curr Opin Urol. 2021 Jun 25. doi: 10.1097/MOU.0000000000000912. Epub ahead of print. PMID: 34175875. 
28. Laser endoscopic procedures on the prostate: it is the small details that count. Taratkin M, Azilgareeva C, Taratkina D, Goryacheva E, Rapoport L, Enikeev D. Curr Opin Urol. 2021 Jul 6. doi: 10.1097/MOU.0000000000000919. Epub ahead of print. 
29. Reasons to go for thulium-based anatomical endoscopic enucleation of the prostate. Becker B, Netsch C, Bozzini G, Herrmann TRW, Bach T, Enikeev D, Gross AJ. World J Urol. 2021 Jul;39(7):2363-2374. doi: 10.1007/s00345-021-03704-7. Epub 2021 May 4. PMID: 33948694. 
30. EAU, AUA and NICE Guidelines on Surgical and Minimally Invasive Treatment of Benign Prostate Hyperplasia: A Critical Appraisal of the Guidelines Using the AGREE-II Tool. Enikeev D, Misrai V, Rijo E, Sukhanov R, Chinenov D, Gazimiev M, Taratkin M, Azilgareeva C, Morozov A, Herrmann TRW, Glybochko P. Urol Int. 2021 Jul 28:1-10. doi: 10.1159/000517675. Epub ahead of print. PMID: 34350885. 
31. Enucleation vs vaporization of benign prostatic hyperplasia: a head-to-head comparison of the various outcomes and complications. A systematic review and meta-analysis. Taratkin M, Shpikina A, Morozov A, Novikov A, Fokin I, Petov V, Rw Herrmann T, Misrai V, Lusuardi L, Teoh JY, McFARLAND J, Kozlov V, Enikeev D. Minerva Urol Nephrol. 2021 Nov 18. doi: 10.23736/S2724-6051.21.04639-5. Epub ahead of print. PMID: 34791865. 
32. Ex vivo study of Ho:YAG and thulium fiber lasers for soft tissue surgery: which laser for which case? Taratkin M, Kovalenko A, Laukhtina E, Paramonova N, Spivak L, Wachtendorf LJ, Eminovic S, Afyouni AS, Okhunov Z, Karagezyan M, Mikhailov V, Strakhov Y, Herrmann TR, Enikeev D. Lasers Med Sci. 2022 Feb;37(1):149-154. doi: 10.1007/s10103-020-03189-7. PMID: 33175250. 
33. Thulium fiber laser in urology: physics made simple. Taratkin M, Azilgareeva C, Cacciamani GE, Enikeev D. Curr Opin Urol. 2022 Mar 1;32(2):166-172. doi: 10.1097/MOU.0000000000000967. PMID: 34954703. 
34. Does Endoscopic Enucleation of the Prostate Need New Lasers? Current Perspective on New Laser Devices. Taratkin M, Enikeev D. Eur Urol Focus. 2022 Mar;8(2):394-395. doi: 10.1016/j.euf.2022.04.002. PMID: 35437230. 
35. Randomized prospective trial of the severity of irritative symptoms after HoLEP vs ThuFLEP. Enikeev D, Taratkin M, Babaevskaya D, Morozov A, Petov V, Sukhanov R, Shpot E, Misrai V, Chinenov D, Enikeev M, Herrmann T. World J Urol. 2022 Aug;40(8):2047-2053. doi: 10.1007/s00345-022-04046-8. PMID: 35690952. 
36. Thulium Fiber Laser Enucleation of the Prostate: Prospective Study of Mid- and Long-Term Outcomes in 1328 Patients. Petov V, Babaevskaya D, Taratkin M, Chuvalov L, Lusuardi L, Misrai V, Sukhanov R, Scoffone CM, Enikeev D. J Endourol. 2022 Sep;36(9):1231-1236. doi: 10.1089/end.2022.0029. PMID: 35414204.
37. Thulium Fiber Laser: Bringing Lasers to a Whole New Level. Enikeev D, Taratkin M. Eur Urol Open Sci. 2022 Dec 20;48:31-33. doi: 10.1016/j.euros.2022.07.007. eCollection 2023 Feb.
38. Thulium fiber laser in endourology: current clinical evidence. Enikeev D, Herrmann TRW, Taratkin M, Azilgareeva C, Borodina A, Traxer O. Curr Opin Urol. 2023 Mar 1;33(2):95-107. doi: 10.1097/MOU.0000000000001057. 
39. Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis. Enikeev D, Morozov A, Bazarkin A, Shpikina A, Brill B, Teoh JY, Suvorov A, Singla N, Taratkin M, Rivas JG, Barret E; ESUT Ablative Group. Minerva Urol Nephrol. 2023 Apr;75(2):154-162. doi: 10.23736/S2724-6051.22.05036-4.
40. Comparison Between Thulium Fiber Laser and High-power Holmium Laser for Anatomic Endoscopic Enucleation of the Prostate: A Propensity Score-matched Analysis from the REAP Registry. Gauhar V, Nedbal C, Castellani D, Fong KY, Sofer M, Socarrás MR, Tursunkulov AN, Ying LK, Elterman D, Mahajan A, Petov V, Ivanovich SN, Bhatia TP, Enikeev D, Gadzhiev N, Chiruvella M, Teoh JY, Galosi AB, Sancha FG, Somani BK, Herrmann TRW. Eur Urol Focus. 2023 Jul 4:S2405-4569(23)00150-5. doi: 10.1016/j.euf.2023.06.009.
41. Holmium laser with MOSES technology (MoLEP) vs Thulium fiber laser enucleation of the prostate (ThuFLEP) in a real-world setting. Mid- term outcomes from a multicenter propensity score analysis. Castellani D, Di Rosa M, Gómez Sancha F, Rodríguez Socarrás M, Mahajan A, Taif Bendigeri M, Taratkin M, Enikeev D, Dellabella M, Gadzhiev N, Somani BK, Herrmann TRW, Gauhar V. World J Urol. 2023 Jul 29. doi: 10.1007/s00345-023-04524-7. Epub ahead of print. PMID: 37515650.
42. Experts' recommendations in laser use for the endoscopic treatment of prostate hypertrophy: a comprehensive guide by the European Section of Uro- Technology (ESUT) and Training-Research in Urological Surgery and Technology (T.R.U.S.T.)-Group. Ortner G, Güven S, Somani BK, Nicklas A, Scoffone CM, Gracco C, Goumas IK, Bach T, Sancha FG, Figueredo FCA, Krambeck A, Bozzini G, Lehrich K, Liatsikos E, Kallidonis P, Roche JB, Miernik A, Enikeev D, Tunc L, Bhojani N, Gilling P, Otero JR, Porreca A, Ahyai S, Netsch C, Gözen AS, Nagele U, Herrmann TRW, Tokas T. World J Urol. 2023 Aug 26. doi: 10.1007/s00345-023-04565-y. 
43. Results from a global multicenter registry of 6193 patients to refine endoscopic anatomical enucleation of the prostate (REAP) by evaluating trends and outcomes and nuances of prostate enucleation in a real-world setting. Gauhar V, Gómez Sancha F, Enikeev D, Sofer M, Fong KY, Rodríguez Socarrás M, Elterman D, Chiruvella M, Bendigeri MT, Tursunkulov AN, Mahajan A, Bhatia TP, Ivanovich SN, Gadzhiev N, Ying LK, Sarvajit B, Dellabella M, Petov V, Somani BK, Castellani D, Herrmann TRW. World J Urol. 2023 Oct 2. doi: 10.1007/s00345-023-04626-2.
44. Laser Ablation Efficiency, Laser Ablation Speed, and Laser Energy Consumption During Lithotripsy: What Are They and How Are They Defined? A Systematic Review and Proposal for a Standardized Terminology. Kwok JL, De Coninck V, Ventimiglia E, Panthier F, Corrales M, Sierra A, Emiliani E, Talso M, Miernik A, Kronenberg P, Enikeev D, Somani B, Ghani KR, Traxer O, Keller EX. Eur Urol Focus. 2023 Nov 6: S2405-4569(23)00222-5. doi: 10.1016/j.euf.2023.10.004.
45. Comparison of EEP and TURP long-term outcomes: systematic review and meta- analysis. Morozov A, Taratkin M, Shpikina A, Ehrlich Y, McFarland J, Dymov A, Kozlov V, Fajkovic H, Rivas JG, Lusuardi L, Teoh JY, Herrmann T, Baniel J, Enikeev D. World J Urol. 2023 Dec;41(12):3471-3483. doi: 10.1007/s00345-023-04666-8.
46. High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group. Ee Jean Lim, Daniele Castellani, Bhaskar K. Somani, Mehmet I. Gokce, Khi Yung Fong, Fernando G. Sancha, Thomas R.W. Herrmann, Sarvajit Biligere, Azimdjon N. Tursunkulov, Marco Dellabella, Mario Sofer, Dmitry Enikeev, Vladislav Petov, Nariman Gadzhiev, Dean Elterman, Abhay Mahajan, Moises R. Socarras, Dilmurod S. Yunusov, Furkat Nasirov, Jeremy Y.C. Teoh, Vineet Gauhar. Prostate International. 2023 Dec. doi: 10.1016/j.prnil.2023.12.001
47. Incidence of urinary incontinence following endoscopic laser enucleation of the prostate by en-bloc and non-en-bloc techniques: a multicenter, real-world experience of 5068 patients. Castellani D, Gauhar V, Fong KY, Sofer M, Socarrás MR, Tursunkulov AN, Ying LK, Biligere S, Tiong HY, Elterman D, Mahajan A, Taratkin M, Ivanovich SN, Bhatia TP, Enikeev D, Gadzhiev N, Bendigeri MT, Teoh JY, Dellabella M, Sancha FG, Somani BK, Herrmann TRW. Asian J Androl. 2024 May 1;26(3):233-238. doi: 10.4103/aja202375.
48. Influence of Early Apical Release on Outcomes in Endoscopic Enucleation of the Prostate: Results From a Multicenter Series of 4392 Patients. Gauhar V, Lim EJ, Fong KY, Gómez Sancha F, Socarrás MR, Enikeev D, Sofer M, Tursunkulov AN, Elterman D, Bendigeri MT, Teoh JY, Mahajan A, Bhatia TP, Ivanovich SN, Gadzhiev N, Ying LK, Sarvajit B, Somani BK, Herrmann TRW, Castellani D. Urology. 2024 Mar 10:S0090-4295(24)00146-8. doi: 10.1016/j.urology.2024.03.003. 
49. Incidence of complications and urinary incontinence following endoscopic enucleation of the prostate in men with a prostate volume of 80 ml and above: results from a multicenter, real-world experience of 2512 patients. Gauhar V, Castellani D, Herrmann TRW, Gökce MI, Fong KY, Gadzhiev N, Malkhasyan V, Pirola GM, Naselli A, Mahajan A, Maheshwari PN, Biligere S, Tursunkulov AN, Nasirov F, Petov V, Dellabella M, Lim EJ, Socarrás MR, Zawadzki M, Cormio L, Busetto GM, Teoh JY, Somani BK, Enikeev D, Sofer M, Gómez Sancha F. World J Urol. 2024 Mar 20;42(1):180. doi: 10.1007/s00345-024-04886-6. 
50. Influence of Prostate Volume on the Incidence of Complications and Urinary Incontinence Following Thulium Fiber Laser Enucleation of the Prostate: Results from Multicenter, Real-world Experience of 2732 patients. Castellani D, Enikeev D, Gokce MI, Petov V, Gadzhiev N, Mahajan A, Maheshwari PN, Fong KY, Tursunkulov AN, Malkhasyan V, Zawadzki M, Sofer M, Cormio L, Busetto GM, Somani BK, Herrmann TRW, Gauhar V. Eur Urol Open Sci. 2024 Mar 21;63:38-43. doi: 10.1016/j.euros.2024.03.004. 
51. Real world propensity score matched analysis evaluating the influence of en-bloc vs. non en-bloc techniques, energy and instrumentation on enucleation outcomes for large and very large prostates. Juliebø-Jones P, Gauhar V, Castellani D, Fong KY, Sofer M, Zawadzki M, Gadzhiev N, Pirola GM, Mahajan AD, Maheshwari PN, Malkhasyan V, Biligere S, Gökce Mİ, Cormio L, Enikeev D, Gómez Sancha F, Herrmann TRW, Somani BK. World J Urol. 2024 May 6;42(1):299. doi: 10.1007/s00345-024-04959-6. PMID: 38710824. 
52. Does concordance between preoperatively measured prostate volume and enucleated weight predict outcomes in endoscopic enucleation of the prostate? Results from the REAP database. Fong KY, Gauhar V, Castellani D, Lim EJ, Sofer M, Enikeev D, Sancha FG, Teoh J, Somani B, Herrmann T. World J Urol. 2024 Aug 7;42(1):470. doi: 10.1007/s00345-024-05194-9. PMID: 39110254.

1. FOCAL LASER THERMOCOAGULATION FOR LOCALIZED PROSTATE CANCER. Glybochko P.V., Vinarov A.Z., Shpot E.V., Sorokin N.I., Dymov A.M., Chinenov D.V., Enikeev D.V., Shmeleva E.A., Koshkarev A.V., Lumpov I.S. Urologiya. 2016. No4. p. 128-136
2. IRREVERSIBLE ELECTROPORATION FOR PROSTATE CANCER (NANOKNIFE). Glybochko P.V., Alyaev Yu.G., Amosov A.V., Enikeev D.V., Chinenov D.V., Krupinov G.E., Chernov Ya.N., Tivtikyan A.S. Urologiya. 2016. No6. p. 153-157
3. EFFICACY OF CRYOABLATION AND EXTRAPERITONEOSCOPIC RADICAL PROSTATECTOMY FPR PROSTATE CANCER. Chernov Ya.N., Rapoport L.M., Amosov A.V., Shpot E.V., Chinenov D.V., Sorokin N.I., Akopyan G.N., Enikeev D.V., Akopyan G.S., Kharchilava R.R. Meditsinsky Vestnik Bashkortostana. May-June 2017. No12(3) p. 69. 
4. COMPARATIVE RESULTS OF CRYOABLATION AND LAPAROSCOPIC RADICAL PROSTATECTOMY IN THE TREATMENT OF LOCALIZED PROSTATE CANCER. Chinenov DV, Rapoport LM, Shpot EV, Enikeev DV, Chernov YN, Taratkin MS, Korolev DO. Urologia. 2018 May;85(2):68-72. doi: 10.1177/0391560317749425. Epub 2018 Mar 25. PubMed PMID: 30043713.
5. FOCAL NEUROENDOCRINE DIFFERENTIATION OF CONVENTIONAL PROSTATE ADENOCARCINOMA AS A PROGNOSTIC FACTOR AFTER RADICAL PROSTATECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS. Kardoust Parizi M, Iwata T, Kimura S, Janisch F, Abufaraj M, Karakiewicz PI, Enikeev D, Rapoport LM, Hutterer G, Shariat SF. Int J Mol Sci. 2019 Mar 19;20(6). pii: E1374. doi: 10.3390/ijms20061374. Review. 
6. FUTURE OF FOCAL THERAPY FOR THE TREATMENT OF PROSTATE CANCER- EUROPEAN SECTION OF UROTECHNOLOGY (ESUT) POSITION. Barret E, Ganzer R, Salomon G, Fielder M, Celia A, Enikeev D, Martínez-Salamanca JI, Liatsikos E, Gómez Rivas J. Arch Esp Urol. 2019 Mar;72(2):167-173.
7. ASSESSMENT OF BODY COMPOSITION IN THE ADVANCED STAGE OF CASTRATION-RESISTANT PROSTATE CANCER: SPECIAL FOCUS ON SARCOPENIA. Stangl-Kremser J, Suarez-Ibarrola R, Andrea D, Korn SM, Pones M, Kramer G, Marhold M, Krainer M, Enikeev DV, Glybochko PV, Tamandl D, Shariat SF, Baltzer P. Prostate Cancer Prostatic Dis. 2019 Nov 19. doi: 10.1038/s41391-019-0186-6. [Epub ahead of print] PubMed PMID: 31745255. 
8. DETECTION OF MARKER MIRNAS, ASSOCIATED WITH PROSTATE CANCER, IN PLASMA USING SOI-NW BIOSENSOR IN DIRECT AND INVERSION MODES. Ivanov Y, Pleshakova T, Malsagova K, Kurbatov L, Popov V, Glukhov A, Smirnov A, Enikeev D, Potoldykova N, Alekseev B, Dolotkazin D, Kaprin A, Ziborov V, Petrov O, Archakov A. Sensors (Basel). 2019 Nov 29;19(23). pii: E5248. doi: 10.3390/s19235248. PubMed PMID:31795306. 
9. EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN NON-METASTATIC PROSTATE CANCER. Kimura S, D'Andrea D, Iwata T, Foerster B, Janisch F, Parizi MK, Moschini M, Briganti A, Babjuk M, Chlosta P, Karakiewicz PI, Enikeev D, Rapoport LM, Seebacher V, Egawa S, Abufaraj M, Shariat SF. World J Urol. 2019 Dec 4. doi: 10.1007/s00345-019-03038-5. [Epub ahead of print] PubMed PMID:31797075. 
10. PROGNOSTIC VALUE OF HEMOGLOBIN IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Janisch F, Mostafaei H, Lysenko I, Karakiewicz PI, Enikeev DV, Briganti A, Kimura S, Egawa S, Shariat SF. Clin Genitourin Cancer. 2019 Dec 13. pii: S1558-7673(19)30375-1. doi: 10.1016/j.clgc.2019.12.002. [Epub ahead of print] Review. PMID: 32007439. 
11. PROGNOSTIC VALUE OF LACTATE DEHYDROGENASE IN METASTATIC PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Kimura S, Parizi MK, Enikeev DV, Glybochko PV, Seebacher V, Fajkovic H, Mostafaei H, Lysenko I, Janisch F, Egawa S, Shariat SF. Clin Genitourin Cancer. 2019 Dec;17(6):409-418. doi: 10.1016/j.clgc.2019.07.009. Epub 2019 Jul 19. Review. PubMed PMID: 31558410. 
12. DEVELOPMENT OF A PROGNOSTIC MODEL FOR SURVIVAL TIME PREDICTION IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS. Stangl-Kremser J, Mari A, Suarez-Ibarrola R, D'Andrea D, Korn SM, Pones M, Kramer G, Karakiewicz P, Enikeev DV, Glybochko PV, Briganti A, Shariat SF. Urol Oncol. 2020 Jan 14. pii: S1078-1439(19)30478-8. doi: 10.1016/j.urolonc.2019.11.005. [Epub ahead of print] PMID: 31953003. 
13. PROGNOSTIC VALUE OF ALKALINE PHOSPHATASE IN HORMONE-SENSITIVE PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Enikeev DV, Kimura S, Egawa S, Shariat SF. Int J Clin Oncol. 2020 Feb;25(2):247-257. doi: 10.1007/s10147-019-01578-9. Epub 2019 Nov 25. Review. PMID: 31768692.
14. THE PROGNOSTIC IMPACT OF TUMOUR NSD2 EXPRESSION IN ADVANCED PROSTATE CANCER. Stangl-Kremser J, Lemberger U, Hassler MR, Garstka N, Grubmüller B, Haitel A, Enikeev DV, Glybochko PV, Kramer G, Susani M, Shariat SF. Biomarkers. 2020 Mar 2:1-6. doi: 10.1080/1354750X.2020.1734861. [Epub ahead of print]. PMID: 32091270. 
15. PROGNOSTIC VALUE OF GLEASON SCORE AT POSITIVE SURGICAL MARGIN IN PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Lysenko I, Mori K, Mostafaei H, Enikeev DV, Karakiewicz PI, Briganti A, Quhal F, Janisch F, Shariat SF. Clin Genitourin Cancer. 2020 Mar 4. pii: S1558-7673(20)30045-8. doi: 10.1016/j.clgc.2020.02.011. [Epub ahead of print] Review. PMID: 32229268. 
16. PLASMA SARCOSINE MEASURED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY DISTINGUISHES PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATE CANCER FROM BENIGN PROSTATE HYPERPLASIA. Markin PA, Brito A, Moskaleva N, Fodor M, Lartsova EV, Shpot YV, Lerner YV, Mikhajlov VY, Potoldykova NV, Enikeev DV, Lyundup AV, Appolonova SA. Lab Med. 2020 Mar 12. pii: lmaa008. doi: 10.1093/labmed/lmaa008. [Epub ahead of print]. PMID: 32161964. 
17. THERE IS A NEED OF NOVEL RISK CLASSIFICATIONS IN PROSTATE CANCER. AN INVITED COMMENTARY ON 'REDUCED CANCER-SPECIFIC SURVIVAL OF LOW PROSTATE-SPECIFIC ANTIGEN IN HIGH-GRADE PROSTATE CANCER: A POPULATION-BASED RETROSPECTIVE COHORT STUDY'. Gómez Rivas J, Enikeev D. Int J Surg. 2020 Mar 12;77:61-62. doi: 10.1016/j.ijsu.2020.03.014. [Epub ahead of print] No abstract available. PMID: 32173613. 
18. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score. Markin PA, Brito A, Moskaleva N, Lartsova EV, Shpot YV, Lerner YV, Mikhajlov VY, Potoldykova NV, Enikeev DV, La Frano MR, Appolonova SA. Metabolomics. DOI: 10.1007/s11306-020-01694-y. 
19. The Risk of New Onset Dementia And/Or Alzheimer's Disease Among Prostate Cancer Patients Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-analysis. Sari Motlagh R, Quhal F, Mori K, Miura N, Aydh A, Laukhtina E, Pradere B, Karakiewicz PI, Enikeev DV, Deuker M, Shariat SF. Journal of Urology. DOI: 10.1097/JU.0000000000001341. 
20. Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes. Enikeev D, Morozov A,Taratkin M, Barret E, Kozlov V, Singla N, Rivas JG, Podoinitsin A, Margulis V, Glybochko P. Clinical Genitourinary Cancer. DOI: 10.1016/j.clgc.2020.05.008. 
21. A systematic review of irreversible electroporation in localised prostate cancer treatment. Morozov A, Taratkin M, Barret E, Singla N, Bezrukov E, Chinenov D, Enikeev M, Gomez Rivas J, Shpikina A, Enikeev D. Andrologia. 2020 Aug 12:e13789. doi: 10.1111/and.13789.
22. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics. Morozov A, Kozlov V, Rivas JG, Teoh JY, Bezrukov E, Amosov A, Barret E, Taratkin M, Salomon G, Herrmann TRW, Gozen A, Enikeev D; collaboration between ESUT, ESUI and Uro-technology WP of the Young Academic Urologists. World J Urol. 2021 Apr 7. doi: 10.1007/s00345-021-03684-8. Epub ahead of print. 
23. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review. Laukhtina E, Sari Motlagh R, Mori K, Quhal F, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Ploussard G, Karakiewicz PI, Briganti A, Abufaraj M, Enikeev D, Pradere B, Shariat SF. World J Urol. 2021 May 28:1-15. doi: 10.1007/s00345-021-03703-8.  
24. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta- Analysis. Chan VW, Tan WS, Asif A, Ng A, Gbolahan O, Dinneen E, To W, Kadhim H, Premchand M, Burton O, Koe JS, Wang N, Leow JJ, Giannarini G, Vasdev N, Shariat SF, Enikeev D, Ng CF, Teoh JY. Cancers (Basel). 2021 Jun 30;13(13):3274. doi: 10.3390/cancers13133274. 
25. A systematic review of nerve-sparing surgery for high-risk prostate cancer. Morozov A, Barret E, Veneziano D, Grigoryan V, Salomon G, Fokin I, Taratkin M, Poddubskaya E, Gomez Rivas J, Puliatti S, Okhunov Z, Cacciamani GE, Checcucci E, Marenco Jiménez JL, Enikeev D; ESUT-YAUWP Group. Minerva Urol Nephrol. 2021 Jun;73(3):283-291. doi: 10.23736/S2724-6051.20.04178-8. Epub 2021 Jan 13. PMID: 33439578. 
26. The role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review. Gómez Rivas J, Carrion DM, Chandrasekar T, Álvarez-Maestro M, Enikeev D, Martínez-Piñeiro L, Barret E. Actas Urol Esp (Engl Ed). 2021 Apr;45(3):188-197. English, Spanish. doi: 10.1016/j.acuro.2020.04.011. Epub 2020 Nov 11. PMID: 33189417. 
27. The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials. Sari Motlagh R, Abufaraj M, Mori K, Aydh A, Rajwa P, Katayama S, Grossmann NC, Laukhtina E, Mostafai H, Pradere B, Quhal F, Karakiewicz PI, Enikeev DV, Shariat SF. Eur Urol Oncol. 2021 Jul 20:S2588-9311(21)00122-X. doi: 10.1016/j.euo.2021.07.002. Epub ahead of print. PMID: 34301529. 
28. Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy. Aydh A, Mori K, D'Andrea D, Motlagh RS, Abufaraj M, Pradere B, Mostafaei H, Laukhtina E, Quhal F, Karakiewicz PI, Luzzago S, Briganti A, Trinh QD, Parizi MK, Tilki D, Enikeev DV, Shariat SF. Int J Clin Oncol. 2021 Sep;26(9):1729-1735. doi: 10.1007/s10147-021-01952-6. Epub 2021 Jun 28. PMID: 34184136; PMCID: PMC8364901. 
29. Isolation of Circulating Tumor Cells from Seminal Fluid of Patients with Prostate Cancer Using Inertial Microfluidics. Rzhevskiy AS, Kapitannikova AY, Vasilescu SA, Karashaeva TA, Razavi Bazaz S, Taratkin MS, Enikeev DV, Lekarev VY, Shpot EV, Butnaru DV, Deyev SM, Thiery JP, Zvyagin AV, Ebrahimi Warkiani M. Cancers (Basel). 2022 Jul 11;14(14):3364. doi: 10.3390/cancers14143364. PMID: 35884424. 
30. A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis. Enikeev D, Morozov A, Babaevskaya D, Bazarkin A, Malavaud B. Cancers (Basel). 2022 Aug 4;14(15):3802. doi: 10.3390/cancers14153802. PMID: 35954464. 
31. Prospective comparison of cognitive and mpMR/US fusion biopsy for prostate cancer detection. Petov VS, Bazarkin AK, Morozov AO, Taratkin MS, Ganzha TM, Danilov SP, Chernov YN, Chinenov DV, Amosov AV, Enikeev DV, Krupinov GE. Urologiia. 2022 Sep;(4):38-43. Russian. PMID: 36098588.
32. Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking. Huang J, Chan EO, Liu X, Lok V, Ngai CH, Zhang L, Xu W, Zheng ZJ, Chiu PK, Vasdev N, Enikeev D, Shariat SF, Ng CF, Teoh JY, Wong MCS. Clin Genitourin Cancer. 2023 Aug;21(4):e261-e270.e50. doi: 10.1016/j.clgc.2023.02.003.
33. Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis. Petov V, Azilgareeva C, Shpikina A, Morozov A, Krupinov G, Kozlov V, Singla N, Gómez Rivas J, Jesús MS, Puliatti S, Checcucci E, Rodler S, Belenchon IR, Kowalewski KF, Veccia A, Mcfarland J, Cacciamani GE, Taratkin M, Enikeev D.
34. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading. Morozov A, Taratkin M, Bazarkin A, Rivas JG, Puliatti S, Checcucci E, Belenchon IR, Kowalewski KF, Shpikina A, Singla N, Teoh JYC, Kozlov V, Rodler S, Piazza P, Fajkovic H, Yakimov M, Abreu AL, Cacciamani GE, Enikeev D; Young Academic Urologists (YAU) Working Group in Uro-technology of the European Association of Urology. Prostate Cancer Prostatic Dis. 2023 Apr 25. doi: 10.1038/s41391-023-00673-3. 
35. A proof-of-concept study on endoscopic ultrasound-guided biopsy of detrusor muscle in porcine bladders. Teoh JY, Cho CL, Chan RC, Liu K, Zhao H, Giannarini G, Enikeev D, Ng CF, Teoh AY. Front Oncol. 2023 Jun 2;13:1160463. doi: 10.3389/fonc.2023.1160463. 
36. Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking. Huang J, Chan EO, Liu X, Lok V, Ngai CH, Zhang L, Xu W, Zheng ZJ, Chiu PK, Vasdev N, Enikeev D, Shariat SF, Ng CF, Teoh JY, Wong MCS. Clin Genitourin Cancer. 2023 Aug;21(4):e261-e270.e50. doi: 10.1016/j.clgc.2023.02.003. Epub 2023 Feb 15.
37. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection. Petov V, Bazarkin A, Morozov A, Taratkin M, Ganzha T, Danilov S, Chernov Y, Chinenov D, Rzayev R, Suvorov A, Amosov A, Fajkovic H, Enikeev D, Krupinov G. J Endourol. 2023 Aug;37(8):940-947. doi: 10.1089/end.2022.0780.
38. Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer. Ivanov YD, Malsagova KA, Goldaeva KV, Kapustina SI, Pleshakova TO, Popov VP, Kozlov AF, Galiullin RA, Shumov ID, Enikeev DV, Potoldykova NV, Ziborov VS, Petrov OF, Dolgoborodov AY, Glukhov AV, Novikov SV, Grabezhova VK, Yushkov ES, Konev VA, Kovalev OB, Archakov AI. Sensors (Basel). 2023 Aug 30;23(17):7527. doi: 10.3390/s23177527.
39. Focal therapy for prostate cancer: a paradigm shift. Babaevskaya D, Morozov A, Tyshkevich G, Martinez-Salamanca JI, Salomon G, Gomez Rivas J, Baniel J, Barret E, Enikeev D. Hellenic Urology. 2024 March; 36 (1):17-22. doi: 10.23736/S2241-9136.24.00023-9. 
40. The Evolving Landscape: Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer Management. Irene De la Parra, Juan Gomez Rivas, Beatriz Gutierrez, Maria J. Marugan, Dmitry Enikeev, Bhaskar K, Somani, Jeronimo Barrera, Jesus Moreno-Sierra. Frontiers in Urology. 2024 Apr; Vol. 4. doi: 10.3389/fruro.2024.1329274
41. A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease. Morozov A, Chuvalov L, Taratkin M, Enikeev M, Rapoport L, Singla N, Barret E, Poddubskaya E, Borodina M, Salomon G, Rivas JG, Enikeev D. Asian J Urol. 2024 Apr;11(2):208-220. doi: 10.1016/j.ajur.2022.03.017. Epub 2022 Nov 29. PMID: 38680575.
42. Cryotherapy versus radical prostatectomy as a salvage treatment for radio-recurrent prostate cancer. Rivas JG, Taratkin M, Azilgareeva C, Morozov A, Laso S, Enikeev D, Sierra JM, Schelkunova K, Sanguedolce F, Breda A, Govorov A, Vasilyev A, Cepeda M, Lusuardi L, Pallauf M, Celia A, Silvestri T, Fiori C, Fernández E, Martínez- Salamanca JI, Barret E. World J Urol. 2024 Sep 11;42(1):515. doi: 10.1007/s00345-024-05199-4. PMID: 39259304.
43. A systematic review of robot-assisted simple prostatectomy outcomes by prostate volume. Morozov A, Bogatova S, Bezrukov E, Singla N, Teoh JY, Spivak L, Rivas JG, Lusuardi L, Gauhar V, Somani B, Lifshitz D, Baniel J, Herrmann TRW, Enikeev D. World J Urol. 2024 Oct 8;42(1):565. doi: 10.1007/s00345-024-05264-y. PMID: 39377921.
44. Current Status of Neoadjuvant Treatment Before Surgery in High-Risk Localized Prostate Cancer. Gómez Rivas J, Ortega Polledo LE, De La Parra Sánchez I, Gutiérrez Hidalgo B, Martín Monterrubio J, Marugán Álvarez MJ, Somani BK, Enikeev D, Puente Vázquez J, Sanmamed Salgado N, Galante Romo MI, Moreno Sierra J. Cancers (Basel). 2024 Dec 31;17(1):99. doi: 10.3390/cancers17010099. PMID: 39796728.

1. PROGNOSTIC VALUE OF T1 SUBSTAGING ON ONCOLOGICAL OUTCOMES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER UROTHELIAL CARCINOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. Kardoust Parizi M, Enikeev D, Glybochko PV, Seebacher V, Janisch F, Fajkovic H, Chłosta PL, Shariat SF. World J Urol. 2019 Sep 6. doi: 10.1007/s00345-019-02936-y. [Epub ahead of print] PubMed PMID: 31493109. 
2. SIX ESSENTIAL CONDITIONS FOR BLADDER-SPARING STRATEGIES IN BACILLUS CALMETTE-GUÉRIN UNRESPONSIVE BLADDER CANCER. Shariat SF, Enikeev DV, Mostafaei H. Immunotherapy. 2019 Sep;11(13):1083-1086. doi: 10.2217/imt-2019-0083. Epub 2019 Aug 6. PubMed PMID: 31385744. 
3. PROGNOSTIC ROLE OF THE UROKINASE PLASMINOGEN ACTIVATOR (UPA) SYSTEM IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER. Iwata T, Kimura S, Abufaraj M, Janisch F, Parizi MK, Haitel A, Rink M, Rouprêt M, Fajkovic H, Seebacher V, Nyirady P, Karakiewicz PI, Enikeev D, Rapoport LM, Nasu Y, Shariat SF. Urol Oncol. 2019 Oct;37(10):774-783. doi: 10.1016/j.urolonc.2019.05.019. Epub 2019 Jun 27. PubMed PMID: 31255543. 
4. THE CHANGING ROLE OF LASERS IN UROLOGIC SURGERY. Enikeev D, Shariat SF, Taratkin M, Glybochko P. Curr Opin Urol. 2020 Jan;30(1):24-29. doi: 10.1097/MOU.0000000000000695. PubMed PMID: 31724998. 
5. EN BLOC RESECTION FOR NONMUSCLE INVASIVE BLADDER CANCER: REVIEW OF THE RECENT LITERATURE. Mori K, D'Andrea D, Enikeev DV, Egawa S, Shariat SF. Curr Opin Urol. 2020 Jan;30(1):41-47. doi: 0.1097/MOU.0000000000000697. PubMed PMID: 31724997. 
6. COMPARATIVE EFFECTIVENESS OF INTRAVESICAL BCG-TICE AND BCG-MOREAU IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER. D'Andrea D, Soria F, Abufaraj M, Pones M, Gontero P, Machado AT, Waksman R, Enikeev DV, Glybochko PV, Adonias SP, Nahas WC, Shariat SF, Chade DC. Clin Genitourin Cancer. 2020 Feb;18(1):20-25.e2. doi: 10.1016/j.clgc.2019.10.021. Epub 2019 Nov 6. PMID: 31786120. 
7. THE PROGNOSTIC VALUE OF THE UROKINASE-PLASMINOGEN ACTIVATOR SYSTEM (UPA) IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY (RC). Janisch F, D'Andrea D, Iwata T, Kimura S, Abufaraj M, Enikeev D, Glybochko PV, Karakiewicz PI, Nyirady P, Fajkovic H, Haitel A, Seebacher V, Rink M, Shariat SF. Urol Oncol. 2020 Mar 21. pii: S1078-1439(20)30043-0. doi: 10.1016/j.urolonc.2020.02.002. [Epub ahead of print]. PMID: 32209281. 
8. NOVEL TECHNOLOGIES THAT CHANGE THE DIAGNOSTIC AND TREATMENT PARADIGM IN UROLOGY: EN-BLOC AS THE NEW TREATMENT STANDARD. Enikeev D, Shariat SF. Curr Opin Urol. 2020 May;30(3):475-476. doi: 10.1097/MOU.0000000000000747. No abstract available. PMID: 32235286. 
9. The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis. Sari Motlagh R, Mori K, Miura N, Quhal F, Aydh A, Laukhtina E, Pradere B, Karakiewicz PI, Enikeev DV, Deuker M, Shariat SF. BJU International. DOI: 10.1111/bju.15146. 
10. Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC). Laukhtina E, Mostafaei H, D'Andrea D, Pradere B, Quhal F, Mori K, Miura N, Schuettfort VM, Sari Motlagh R, Aydh A, Abufaraj M, Karakiewicz PI, Enikeev D, Kimura S, Shariat SF. World Journal of Urology. DOI: 10.1007/s00345-020-03384-9. 
11. Safety and Short-Term Oncological Outcomes of Thulium Fiber Laser en Bloc Resection of Non-Muscle-Invasive Bladder Cancer: A Prospective Non-Randomized Phase II Trial. Enikeev, D., Taratkin, M., Margulis, V., Sorokin, N., Severgina, L., Paramonova, N., Kislyakov, D., Kozlov, V., Rapoport, L., Shariat, S.F., Glybochko, P. Bladder Cancer, 6 (2), pp. 201-210. 10.3233/BLC-200275.  
12. Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method. Glukhov A, Potoldykova N, Taratkin M, Gordeev S, Polyakovsky K, Laukhtina E, Moschini M, Abufaraj M, Shariat SF, Sekacheva M, Enikeev D, Glybochko P. J Clin Med. 2021 Mar 4;10(5):1055. doi: 10.3390/jcm10051055.
13. Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence. Laukhtina E, Abufaraj M, Al-Ani A, Ali MR, Mori K, Moschini M, Quhal F, Sari Motlagh R, Pradere B, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NC, Fajkovic H, Soria F, Enikeev D, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Eur Urol Focus. 2021 Mar 21:S2405-4569(21)00095-X. doi: 10.1016/j.euf.2021.03.016. 
14. Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review. Laukhtina E, Pradere B, Mori K, Schuettfort VM, Quhal F, Mostafaei H, Sari Motlagh R, Aydh A, Moschini M, Enikeev D, Karakiewicz PI, Abufaraj M, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Urol Oncol. 2021 Apr 19:S1078-1439(21)00115-0. doi: 10.1016/j.urolonc.2021.03.005.  
15. Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis. Laukhtina E, Rajwa P, Mori K, Moschini M, D'Andrea D, Abufaraj M, Soria F, Mari A, Krajewski W, Albisinni S, Teoh JY, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NC, Enikeev D, Zimmermann K, Fajkovic H, Glybochko P, Shariat SF, Pradere B; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group (EAU YAU). Eur Urol Focus. 2021 Jun 11:S2405-4569(21)00162-0. doi: 10.1016/j.euf.2021.05.010. Online ahead of print.
16. Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis. Laukhtina E, Mori K, D Andrea D, Moschini M, Abufaraj M, Soria F, Mari A, Krajewski W, Albisinni S, Teoh JY, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NС, Rajwa P, Enikeev D, Zimmermann K, Fajkovic H, Glybochko P, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Urol Oncol. 2021 Jul 12:S1078-1439(21)00267-2. doi: 10.1016/j.urolonc.2021.06.009. Online ahead of print. 
17. Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis. Laukhtina E, Mori K, Mostafaei H, Merseburger AS, Nyirady P, Moschini M, Quhal F, Schuettfort VM, Pradere B, Motlagh RS, Enikeev D, Shariat SF, Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group EA. Immunotherapy. 2021 Aug;13(11):917-929. doi: 10.2217/imt-2020-0305. Epub 2021 Jun 3.PMID: 34078134. 
18. Impact of the preoperative modified glasgow prognostic score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder. Schuettfort VM, Gust K, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. Minerva Urol Nephrol. 2021 Jun 11. doi: 10.23736/S2724-6051.21.04216-6. Epub ahead of print. PMID: 34114784. 
19. Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials. Laukhtina E, Mori K, Mostafaei H, Merseburger AS, Nyirady P, Moschini M, Quhal F, Pradere B, Motlagh RS, Enikeev D, Shariat SF; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Semin Oncol. 2021 Jun;48(3):181-192. doi: 10.1053/j.seminoncol.2021.09.005. Epub 2021 Oct 2. PMID: 34749886.
20. Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review. Laukhtina E, Pradere B, Mori K, Schuettfort VM, Quhal F, Mostafaei H, Sari Motlangh R, Katayama S, Grossmann NC, Moschini M, Enikeev D, Shariat SF; European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Urol Oncol. 2021 Mar;39(3):180-190. doi: 10.1016/j.urolonc.2020.12.019. Epub 2021 Jan 8. PMID: 33423937. 
21. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. Schuettfort VM, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. BJU Int. 2021 Mar 1. doi: 10.1111/bju.15379. Epub ahead of print. PMID: 33650265. 
22. hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review. Morozov A, Potoldykova N, Chinenov D, Enikeev M, Glukhov A, Shpikina A, Goryacheva E, Taratkin M, Malavaud B, Enikeev D. Urol Oncol. 2021 Aug;39(8):498.e21-498.e33. doi: 10.1016/j.urolonc.2021.01.022. Epub 2021 Mar 3. PMID: 33676848. 
23. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer. Quhal F, Pradere B, Laukhtina E, Sari Motlagh R, Mostafaei H, Mori K, Schuettfort VM, Karakiewicz PI, Rouprêt M, Enikeev D, Rink M, Abufaraj M, Shariat SF. World J Urol. 2021 Sep;39(9):3345-3352. doi: 10.1007/s00345-020-03586-1. Epub 2021 Jan 26. PMID: 33496841; PMCID: PMC8510920. 
24. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. Schuettfort VM, Pradere B, D'Andrea D, Grossmann NC, Quhal F, Mostafaei H, Laukhtina E, Mori K, Rink M, Karakiewicz PI, Motlagh RS, Katayama S, Lotan Y, Scherr D, Abufaraj M, Fajkovica H, Compérat E, Enikeev D, Shariat SF. J Urol. 2021 Nov;206(5):1122-1131. doi: 10.1097/JU.0000000000001936. Epub 2021 Jun 28. PMID: 34181469. 
25. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Laukhtina E, Shim SR, Mori K, D'Andrea D, Soria F, Rajwa P, Mostafaei H, Compérat E, Cimadamore A, Moschini M, Teoh JY, Enikeev D, Xylinas E, Lotan Y, Palou J, Gontero P, Babjuk M, Witjes JA, Kamat AM, Roupret M, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Eur Urol Oncol. 2021 Nov 6:S2588-9311(21)00183-8. doi: 10.1016/j.euo.2021.10.003. Epub ahead of print. PMID: 34753702. 
26. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta- Analysis. Zhao H, Chan VW, Castellani D, Chan EO, Ong WLK, Peng Q, Moschini M, Krajewski W, Pradere B, Ng CF, Enikeev D, Vasdev N, Ekin G, Sousa A, Leon J, Guerrero-Ramos F, Tan WS, Kelly J, Shariat SF, Witjes JA, Teoh JY. Front Surg. 2021 Nov 23;8:775527. doi: 10.3389/fsurg.2021.775527. PMID: 34888347; PMCID: PMC8649716. 
27. Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Laukhtina E, Schuettfort VM, D'Andrea D, Pradere B, Mori K, Quhal F, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NС, Rajwa P, Zeinler F, Abu Faraj M, Moschini M, Zimmermann K, Karakiewicz PI, Fajkovic H, Scherr D, Compérat E, Nyirady P, Rink M, Enikeev D, Shariat SF. Mol Carcinog. 2022 Jan;61(1):5-18. doi: 10.1002/mc.23355. Epub 2021 Sep 29. PMID: 34587660. 
28. En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser. Enikeev D, Babjuk M, Shpikina A, Shariat S, Glybochko P. Curr Opin Urol. 2022 Mar 1;32(2):173-178. doi: 10.1097/MOU.0000000000000968. PMID: 34954702. 
29. Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group. Laukhtina E, Moschini M, Soria F, Andrea DD, Teoh JY, Mori K, Albisinni S, Mari A, Krajewski W, Cimadamore A, Abufaraj M, Enikeev D, Neuzillet Y, Giannarini G, Xylinas E, Kamat AM, Roupret M, Babjuk M, Witjes JA, Shariat SF, Pradere B; European Association of Urology; Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group; European Association of Urology Section of Oncological Urology ESOU. Eur Urol Focus. 2022 Mar 22:S2405-4569(22)00058-X. doi: 10.1016/j.euf.2022.03.004. PMID: 35337773. 
30. How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey. Guven S, Colecchia M, Oltulu P, Bonfante G, Enikeev D, Esen H, Herrmann T, Lusuardi L, Micali S, Somani B, Skolarikos A, Breda A, Liatsikos E, Redorta JP, Gozen AS. World J Urol. 2022 May 14. doi: 10.1007/s00345-022-04022-2. PMID: 35567624. 
31. Systematic Review: The Learning Curve for Robot-Assisted Radical Cystectomy-What Do We Know? Morozov A, Babaevskaya D, Taratkin M, Inoyatov J, Laukhtina E, Moschini M, Singla N, Gomez Rivas J, Teoh JY, Glybochko P, Enikeev D. J Endourol. 2022 Jun;36(6):770-784. doi: 10.1089/end.2021.0388. PMID: 35156854.
32. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study. Laukhtina E, Boehm A, Peyronnet B, Bravi CA, Batista Da Costa J, Soria F, D'Andrea D, Rajwa P, Quhal F, Yanagisawa T, König F, Mostafaei H, Enikeev D, Ingels A, Verhoest G, D'Hondt F, Mottrie A, Joniau S, Van Poppel H, de la Taille A, Bensalah K, Bruyère F, Shariat SF, Pradere B. World J Urol. 2022 Jul;40(7):1689-1696. doi: 10.1007/s00345-022-04025-z. PMID: 35596017; PMCID: PMC9236994. 
33. Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis". Laukhtina E, Shim SR, Mori K, D'Andrea D, Soria F, Rajwa P, Mostafaei H, Compérat E, Cimadamore A, Moschini M, Teoh JY, Enikeev D, Xylinas E, Lotan Y, Palou J, Gontero P, Babjuk M, Witjes JA, Kamat AM, Roupret M, Shariat SF, Pradere B; European Association of Urology–Young Academic Urologists EAU-YAU Urothelial Carcinoma Working Group. Eur Urol Oncol. 2022 Aug;5(4):480-481. doi: 10.1016/j.euo.2022.01.003. PMID: 35063436. 
34. Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate. Laukhtina E, Moschini M, Krajewski W, Teoh JY, Ploussard G, Soria F, Roghmann F, Muenker MA, Roumiguie M, Alvarez-Maestro M, Misrai V, Antonelli A, Tafuri A, Simone G, Mastroianni R, Zhao H, Rahota RG, D'Andrea D, Mori K, Albisinni S, Karakiewicz PI, Fajkovic H, Enikeev D, Montorsi F, Shariat SF, Pradere B; European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. BJU Int. 2022 Sep 22. doi: 10.1111/bju.15898.
35. 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough? Enikeev D, Morozov A, Shpikina A, Fajkovic H, Baniel J, Herrmann TRW. A
    World J Urol. 2023 May 27. doi: 10.1007/s00345-023-04439-3.
36. A proof-of-concept study on endoscopic ultrasound-guided biopsy of detrusor muscle in porcine bladders. Teoh JY, Cho CL, Chan RC, Liu K, Zhao H, Giannarini G, Enikeev D, Ng CF, Teoh AY. Front Oncol. 2023 Jun 2;13:1160463. doi: 10.3389/fonc.2023.1160463.
37. Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis. Laukhtina E, von Deimling M, Pradere B, Yanagisawa T, Rajwa P, Kawada T, Quhal F, Pallauf M, Bianchi A, Majdoub M, Mostafaei H, Sari Motlagh R, Mori K, Enikeev D, Fisch M, Moschini M, D'Andrea D, Soria F, Albisinni S, Fajkovic H, Rink M, Teoh JY, Gontero P, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. BJU Int. 2023 Aug 10. doi: 10.1111/bju.16152.
38. For Which Patients Should Bladder Preservation Be Considered After a Complete Response to Neoadjuvant Chemotherapy. Laukhtina E, Quhal F, von Deimling M, Kawada T, Yanagisawa T, Rajwa P, Majdoub M, Enikeev D, Shariat SF. Eur Urol Focus. 2023 May 5:S2405-4569(23)00106-2. doi: 10.1016/j.euf.2023.04.009.
39. Current Techniques for En Bloc Transurethral Resection of Bladder Tumor: A Hands-on Guide Through the Energy Landscape. Nicoletti R, Gauhar V, Castellani D, Enikeev D, Herrmann TRW, Teoh JY. Eur Urol Focus. 2023 May 11:S2405-4569(23)00104-9. doi: 10.1016/j.euf.2023.04.007
40. 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough? Enikeev D, Morozov A, Shpikina A, Fajkovic H, Baniel J, Herrmann TRW. A World J Urol. 2023 May 27. doi: 10.1007/s00345-023-04439-3.
41. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. D'Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, Xylinas E, Lusuardi L, Heidenreich A, Cai C, Frego N, Taraktin M, Ryabov M, Gontero P, Compérat E, Shariat SF; eBLOC Study Team. Eur Urol Oncol. 2023 Aug 3:S2588-9311(23)00154-2. doi: 10.1016/j.euo.2023.07.010.
42. Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis. Laukhtina E, von Deimling M, Pradere B, Yanagisawa T, Rajwa P, Kawada T, Quhal F, Pallauf M, Bianchi A, Majdoub M, Mostafaei H, Sari Motlagh R, Mori K, Enikeev D, Fisch M, Moschini M, D'Andrea D, Soria F, Albisinni S, Fajkovic H, Rink M, Teoh JY, Gontero P, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. BJU Int. 2023 Aug 10. doi: 10.1111/bju.16152.
43. En bloc resection of bladder tumour: the rebirth of past through reminiscence. Teoh JY, D'Andrea D, Gallioli A, Yanagisawa T, MacLennan S, Nicoletti R, Fai NC, Maffei D, Hurle R, Lusuardi L, Malavaud B, Miki J, Kramer M, Mostafid H, Enikeev D, Babjuk M, Breda A, Shariat S, Gontero P, Herrmann T. World J Urol. 2023 Aug 16. doi: 10.1007/s00345-023-04547-0.
44. A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer. Kang Liu, Hongda Zhao, Xuan Chen, Rossella Nicoletti, Nikhil Vasdev, Peter Ka-Fung Chiu, Chi-Fai Ng, Tatsushi Kawada, Ekaterina Laukhtina, Keiichiro Mori, Takafumi Yanagisawa, David D’Andrea, Markus von Deimling, Simone Albisinni, Wojciech Krajewski, Benjamin Pradere, Francesco Soria,  Marco Moschini, Dmitry Enikeev, Shahrokh Shariat, Ashish Kamat, Gianluca Giannarini, Jeremy Yuen-Chun Teoh, on behalf of the European Association of Urology—Young Academic Urologists Urothelial Carcinoma Working Group. Eur Urol Oncol. 2023. doi: 10.1016/j.euo.2023.09.014
45. Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature. Ripa F, Enikeev D, Talyshinskii A, Juliebø-Jones P, Tzelves L, Kallidonis P, Somani B. Curr Opin Urol. 2023 Nov 7. doi: 10.1097/MOU.0000000000001146.
46. Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. D'Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, Xylinas E, Lusuardi L, Heidenreich A, Cai C, Frego N, Taraktin M, Ryabov M, Gontero P, Compérat E, Shariat SF; eBLOC Study Team. Eur Urol Oncol 2023;6:508-15. Eur Urol Oncol. 2023 Nov 15:S2588-9311(23)00242-0. doi: 10.1016/j.euo.2023.10.026. 
47. Experts’ recommendations in laser use for the treatment of bladder cancer: a comprehensive guide by the European Section of Uro‑Technology (ESUT) and Training and Research in Urological Surgery and Technology (TRUST)‑Group. Gernot Ortner, Selcuk Güven, Bhaskar Kumar Somani, Andre Nicklas, Jeremy Yuen‑Chun Teoh, Ioannis Kartalas Goumas, Thorsten Bach, Fernando Gómez Sancha, Felipe C. A. Figueredo, Mario W. Kramer, Giorgio Bozzini, Øyvind Ulvik, Panagiotis Kallidonis, Jean Baptiste Roche, Arkadiusz Miernik, Dmitry Enikeev, Chandra Mohan Vaddi, Naeem Bhojani, Petros Sountoulides, Lukas Lusuardi, Joyce Baard, Vineet Gauhar, Ali Ahmed, Christopher Netsch, Ali Serdar Gözen, Udo Nagele,  Thomas R. W. Herrmann, Theodoros Tokas. World Journal of Urology (2024) 42:79. doi: 10.1007/s00345-024-04786-9.
48. Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. D'Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, Xylinas E, Lusuardi L, Heidenreich A, Cai C, Frego N, Taraktin M, Ryabov M, Gontero P, Compérat E, Shariat SF; eBLOC Study Team. Eur Urol Oncol. 2023;6:508-515. Eur Urol Oncol. 2024 Aug;7(4):967-968. doi: 10.1016/j.euo.2023.10.001. 
49. Prospective non-randomized comparison of transurethral laser en bloc resection vs. conventional resection of bladder tumors larger than 3 cm. Petov V, Timofeeva E, Sukhanov R, Baniel J, Mustafin M, Fajkovic H, Morozov A, Teoh JY, Singla N, Laukhtina E, Herrmann TR, Shariat SF, Enikeev D. Minerva Urol Nephrol. 2024 Aug;76(4):436-441. doi: 10.23736/S2724-6051.24.05682-9. PMID: 39051891.
50. Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancer. Liu K, Nicoletti R, Zhao H, Chen X, Wu H, Leung CH, D'Andrea D, Laukhtina E, Soria F, Gallioli A, Wroclawski ML, Castellani D, Gauhar V, Rivas JG, Enikeev D, Gontero P, Shariat SF, Chiu PK, Ng CF, Teoh JY. World J Urol. 2024 Sep 27;42(1):547. doi: 10.1007/s00345-024-05218-4. PMID: 39331198.
51. En bloc resection of large bladder tumor: is it feasible and reasonable? Babaevskaya D, Morozov A, Fridman E, Tsoy L, Shariat SF, Molchanov Y, Yakimov M, Compérat E, Herrmann TRW, Enikeev D. Curr Opin Urol. 2025 Jan 21. doi: 10.1097/MOU.0000000000001265. PMID: 39834157.
52. Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research network. Pallauf M, Brönimann S, Rezaee ME, Kohn TP, Fletcher SA, McNamara M, Enikeev D, Shariat SF, Hoffman-Censits J, Smith AK, Singla N. Urol Oncol. 2025 Jan 22:S1078-1439(24)01055-X. doi: 10.1016/j.urolonc.2024.12.275. PMID: 39848843.

1. CRYOBLATION IN UROLOGY. Glybochko P.V., Alyaev Yu.G., Amosov A.V., Enikeev D.V., Chinenov D.V., Lumpov I.S., Vorobiev A.A. Urologiya. 2014. No6. p. 108-112.
2. LASER RADIATION IN RENAL CANCER RESECTION. Dymov A.M., Glybochko P.V., Alyaev Yu.G., Vinarov A.Z., Shpot E.V., Sorokin N.I., Enikeev D.V., Koshkarev A.V., Shmeleva E.A., Yurova M.V. Urologiya. 2016. No6. p. 142-148
3. ULTRASOUND-GUIDED PERCUTANEOUS CRYOBLATION FOR RENAL CANCER. Enikeev D.V., Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Amosov A.V., Alekseeva T.M., Enikeev M.E., Tsarichenko D.G., Chinenov D.V., Kozmin L.D., Dzhalaev Z.K., Taratkin M.S. Urologiya.2017;3:68-73
4. PERCUTANEOUS US-GUIDED RENAL CRYOABLATION USING 3D MODELING. Rapoport LM, Cytron S, Enikeev ME, Tsarichenko DG, Enikeev DV, Chinenov DV. Urologia. 2017 Aug 1;84(3):174-178. doi: 10.5301/uj.5000231. Epub 2017 May 10. 
5. A prospective study of novel mathematical analysis of the contrast-enhanced computed tomography vs renal scintigraphy in renal function evaluation. Fiev D, Proskura A, Khokhlachev S, Taratkin M, Borisov V, Chernenkiy M, Gabdulina S, Leonard SP, Alyaev Y, Rivas JG, Enikeev D, Glybochko P. European Journal of Radiology. DOI: 10.1016/j.ejrad.2020.109169. 
6. Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Laukhtina E, Pradere B, D Andrea D, Rosiello G, Luzzago S, Pecoraro A, Palumbo C, Knipper S, Karakiewicz PI, Margulis V, Quhal F, Sari Motlagh R, Mostafaei H, Mori K, Kimura S, Enikeev D, Shariat SF. Urol Oncol. 2020 Sep 19:S1078-1439(20)30380-X. doi: 10.1016/j.urolonc.2020.08.013. 
7. Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Laukhtina E, Pradere B, D'Andrea D, Rosiello G, Luzzago S, Pecoraro A, Palumbo C, Knipper S, Karakiewicz PI, Margulis V, Quhal F, Motlagh RS, Mostafaei H, Mori K, Schuettfort VM, Enikeev D, Shariat SF. Transl Androl Urol. 2021 Feb;10(2):609-619. doi: 10.21037/tau-20-1101. 
8. Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Laukhtina E, Pradere B, D'Andrea D, Rosiello G, Luzzago S, Pecoraro A, Palumbo C, Knipper S, Karakiewicz PI, Margulis V, Quhal F, Sari Motlagh R, Mostafaei H, Mori K, Schuettfort VM, Enikeev D, Shariat SF. Minerva Urol Nephrol. 2021 Mar 26. doi: 10.23736/S2724-6051.21.04023-6. 
9. Changes in Protein Structural Motifs upon Post-Translational Modification in Kidney Cancer. Tikhonov D, Kulikova L, Rudnev V, Kopylov AT, Taldaev A, Stepanov A, Malsagova K, Izotov A, Enikeev D, Potoldykova N, Kaysheva A. Diagnostics (Basel). 2021 Oct 4;11(10):1836. doi: 10.3390/diagnostics11101836. PMID: 34679534; PMCID: PMC8534394. 
10. Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate. Dilme RV, Rivas JG, Campi R, Puente J, Jerez T, Enikeev D, Esperto F, Sierra JM.? Curr Urol Rep. 2021 Oct 16;22(11):54. doi: 10.1007/s11934-021-01073-7. PMID: 34654989. 
11. Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach. Laukhtina E, Schuettfort VM, D'Andrea D, Pradere B, Quhal F, Mori K, Sari Motlagh R, Mostafaei H, Katayama S, Grossmann NC, Rajwa P, Karakiewicz PI, Schmidinger M, Fajkovic H, Enikeev D, Shariat SF. World J Urol. 2021 Oct 20. doi: 10.1007/s00345-021-03844-w. Epub ahead of print. PMID: 34671856. 
12. Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis. Laukhtina E, Quhal F, Mori K, Sari Motlagh R, Pradere B, Schuettfort VM, Mostafaei H, Katayama S, Grossmann NС, Rajwa P, Resch I, Enikeev D, Karakiewicz PI, Shariat SF, Schmidinger M. Urol Oncol. 2021 Nov;39(11):764-773. doi: 10.1016/j.urolonc.2021.07.022. Epub 2021 Aug 14. PMID: 34400065. 
13. Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy. Laukhtina E, Quhal F, Mori K, Sari Motlagh R, Rajwa P, Yanagisawa T, Mostafaei H, König F, Aydh A, Pradere B, Enikeev D, Karakiewicz PI, Schmidinger M, Shariat SF. Eur Urol Oncol. 2022 Feb;5(1):120-124. doi: 10.1016/j.euo.2021.12.007. PMID: 34992006. 
14. Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma. Rabinowitz MJ, Esfandiary T, Cheaib J, Patel SH, Alam R, Metcalf M, Enikeev D, Pierorazio PM, Ged YMA, Allaf ME, Singla N. Eur Urol Open Sci. 2022 Jul 25;43:28-34. doi: 10.1016/j.euros.2022.07.001. 
15. Evaluation of Growth Rates for Small Renal Masses in Elderly Patients Undergoing Active Surveillance. Alam R, Yerrapragada A, Wlajnitz T, Watts E, Pallauf M, Enikeev D, Chang P, Wagner AA, McKiernan JM, Pierorazio PM, Allaf ME, Singla N. Eur Urol Open Sci. 2023 Mar 1;50:78-84. doi: 10.1016/j.euros.2023.02.004.
16. A novel less-traumatic needle for kidney puncture: first clinical experience. Morozov A, Kalinin N, Androsov A, McFarland J, Scolarikos A, Saidian D, Gomez Rivas J, Somani B, Enikeev D, Glybochko P, Gazimiev M. Int Urol Nephrol. 2023 Aug;55(8):1931-1936. doi: 10.1007/s11255-023-03584-3.
17. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma. Alam R, Rezaee ME, Pallauf M, Elias R, Yerrapragada A, Enikeev D, Fang D, Shariat SF, Woldu SL, Ged YMA, Singla N. Urol Oncol. 2023 Sep 13:S1078-1439(23)00291-0. doi: 10.1016/j.urolonc.2023.08.016
18. Kidney computed tomography perfusion in patients with ureteral obstruction. Belyaeva K, Rudenko V, Serova N, Morozov A, Taratkin M, Androsov A, Singla N, Shpunt I, Gomez Rivas J, Fajkovic H, Enikeev D, Kapanadze L. Urologia. 2024 Apr 26:3915603241244935. doi: 10.1177/03915603241244935.
19. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, Gümüş M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B; LITESPARK-005 Investigators. N Engl J Med. 2024 Aug 22;391(8):710-721. doi: 10.1056/NEJMoa2313906. PMID: 39167807.

1. RISK STRATIFICATION OF UPPER TRACT UROTHELIAL CARCINOMA: A REVIEW OF THE CURRENT LITERATURE. Kardoust Parizi M, Glybochko PV, Enikeev D, Rouprêt M, Fajkovic H, Seebacher V, Shariat SF. Expert Rev Anticancer Ther. 2019 Jun;19(6):503-513. doi: 10.1080/14737140.2019.1621753. Epub 2019 May 27. PubMed PMID: 31131643. 
2. PROGNOSTIC VALUE OF VARIANT HISTOLOGY IN UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Kimura S, Enikeev DV, Egawa S, Shariat SF. J Urol. 2019 Sep 3:101097JU0000000000000523. doi: 10.1097/JU.0000000000000523. [Epub ahead of print] PubMed PMID: 31479406.
3. DIFFERENTIAL EFFECT OF SEX ON OUTCOMES AFTER RADICAL SURGERY FOR UPPER TRACT AND BLADDER UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. Mori K, Mostafaei H, Enikeev DV, Lysenko I, Quhal F, Kimura S, Karakiewicz PI, Egawa S, Shariat SF. J Urol. 2020 Jan 29:101097JU0000000000000788. doi: 10.1097/JU.0000000000000788. [Epub ahead of print]. PMID: 31995432. 
4. PROGNOSTIC VALUE OF THE SYSTEMIC INFLAMMATION MODIFIED GLASGOW PROGNOSTIC SCORE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH RADICAL NEPHROURETERECTOMY: RESULTS FROM A LARGE MULTICENTER INTERNATIONAL COLLABORATION. Soria F, Giordano A, D'Andrea D, Moschini M, Rouprêt M, Margulis V, Karakiewicz PI, Briganti A, Bensalah K, Mathieu R, Chlosta P, Babjuk M, Glybochko PV, Enikeev DV, Remzi M, Gust K, Gontero P, Shariat SF. Urol Oncol. 2020 Feb 6. pii: S1078-1439(20)30005-3. doi: 10.1016/j.urolonc.2020.01.004. [Epub ahead of print]. PMID: 32037197.
5. PROGNOSTIC ROLE OF PREOPERATIVE DE RITIS RATIO IN UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY. Mori K, Janisch F, Mostafaei H, Kimura S, Lysenko I, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Chlosta P, Nyirady P, Babjuk M, Egawa S, Shariat SF. Urol Oncol. 2020 Feb 29. pii: S1078-1439(20)30049-1. doi: 10.1016/j.urolonc.2020.02.008. [Epub ahead of print]. PMID: 32127252. 
6. Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma. Katayama S, Mori K, Schuettfort VM, Pradere B, Mostafaei H, Quhal F, Rajwa P, Motlagh RS, Laukhtina E, Moschini M, Grossmann NC, Araki M, Teoh JY, Rouprêt M, Margulis V, Enikeev D, Karakiewicz PI, Abufaraj M, Compérat E, Nasu Y, Shariat SF. Eur Urol Focus. 2021 May 27:S2405-4569(21)00154-1. doi: 10.1016/j.euf.2021.05.002. Epub ahead of print. PMID: 34053904. 
7. Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. Miura N, Mori K, Laukhtina E, Schuettfort VM, Abufaraj M, Teoh JYC, Luzzago S, Stolzenbach F, Deuker M, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Chlosta P, Nyirady P, Babjuk M, Egawa S, Saika T, Shariat SF. Jpn J Clin Oncol. 2021 Jul 1;51(7):1149-1157. doi: 10.1093/jjco/hyab023. PMID: 33667307. 
8. Prognostic role of the systemic immune- inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. Mori K, Resch I, Miura N, Laukhtina E, Schuettfort VM, Pradere B, Katayama S, D'Andrea D, Kardoust Parizi M, Abufaraj M, Fukuokaya W, Collà Ruvolo C, Luzzago S, Knipper S, Palumbo C, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Egawa S, Shariat SF. Cancer Immunol Immunother. 2021 Sep;70(9):2641-2650. doi: 10.1007/s00262-021-02884-w. Epub 2021 Feb 16. PMID: 33591412; PMCID: PMC8360829. 
9. Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. Mori K, Katayama S, Laukhtina E, Schuettfort VM, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P, Zimmermann K, Karakiewicz PI, Abufaraj M, Fajkovic H, Rouprêt M, Margulis V, Enikeev DV, Egawa S, Shariat SF. Clin Genitourin Cancer. 2021 Oct 10:S1558-7673(21)00192-0. doi: 10.1016/j.clgc.2021.10.002. Epub ahead of print. PMID: 34764007. 
10. Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma. Ghandour RA, Freifeld Y, Cheaib J, Singla N, Meng X, Kenigsberg A, Bagrodia A, Woldu S, Hoffman-Censits J, Enikeev D, Rapoport L, Petros FG, Raman JD, Pierorazio PM, Matin SF, Margulis V. Urol Oncol. 2021 Nov;39(11):788.e15-788.e21. doi: 10.1016/j.urolonc.2021.05.037. Epub 2021 Jul 28. PMID: 34330655. 
11. Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations. Laukhtina E, Lemberger U, Bruchbacher A, Ilijazi D, Korn S, Berndl F, D'Andrea D, Susani M, Enikeev D, Compérat E, Shariat SF, Hassler MR. J Pers Med. 2021 Nov 4;11(11):1147. doi: 10.3390/jpm11111147. PMID: 34834500; PMCID: PMC8625702. 
12. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta- analysis of oncologic and toxicity outcomes. Laukhtina E, Motlagh RS, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Crit Rev Oncol Hematol. 2021 Dec 10:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub ahead of print. PMID: 34902554. 
13. Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma. Laukhtina E, Hassler MR, Pradere B, Yanagisawa T, Quhal F, Rajwa P, Sari Motlagh R, König F, Pallauf M, Kawada T, Mostafaei H, D'Andrea D, Enikeev D, Shariat SF. Eur Urol Focus. 2022 May 10:S2405-4569(22)00112-2. doi: 10.1016/j.euf.2022.04.017. PMID: 35562252. 
14. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Crit Rev Oncol Hematol. 2022 Jan;169:103570. doi: 10.1016/j.critrevonc.2021.103570.
15. Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis. Laukhtina E, Kawada T, Quhal F, Yanagisawa T, Rajwa P, von Deimling M, Pallauf M, Bianchi A, Majdoub M, Enikeev D, Fajkovic H, Teoh JY, Rouprêt M, Gontero P, Shariat SF. Eur Urol Focus. 2023 Mar;9(2):258-263. doi: 10.1016/j.euf.2022.11.014.
16. Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis. Kawada T, Laukhtina E, Quhal F, Yanagisawa T, Rajwa P, Pallauf M, von Deimling M, Bianchi A, Pradere B, Fajkovic H, Enikeev D, Gontero P, Rouprêt M, Seisen T, Araki M, Shariat SF. Eur Urol Focus. 2023 Mar;9(2):236-240. doi: 10.1016/j.euf.2022.11.016.
17. A Review of How Lasers Are Used in UTUC Surgery: Can the Choice of Laser Affect Outcomes? Taratkin M, Singla N, Babaevskaya D, Androsov A, Shariat SF, Fajkovic H, Baniel J, Enikeev D. Cancers (Basel). 2023 Mar 21;15(6):1874. doi: 10.3390/cancers15061874.
18. Global burden, risk factors, and temporal trends of ureteral cancer: a comprehensive analysis of cancer registries. Huang J, Pang WS, Fung YC, Mak FY, Chan SC, Liu X, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Moschini M, Pradere B, Soria F, Enikeev D, Roupret M, Shariat S, Ng AC, Teoh JY, Wong MCS. BMC Med. 2024 Jun 24;22(1):264. doi: 10.1186/s12916-024-03485-x. PMID: 38915094.

1. LAPAROSCOPIC PYELOLITHOTOMY AND ITS ROLE IN CONTEMPORARY SURGERY FOR NEPHROLITHIASIS. Glybochko P.V., Alyaev Yu.G., Rapoport L.M., Enikeev M.E., Tsarichenko D.G., Shpot E.V., Korolev D.O., Vorobiev A.A., Enikeev D.V. Urologiya.2017;4:12-17 
2. EFFECT OF OPTICAL FIBER DIAMETER AND LASER EMISSION MODE (CW VS PULSE) ON TISSUE DAMAGE PROFILE USING 1.94 µM TM:FIBER LASERS IN A PORCINE KIDNEY MODEL. Becker B, Enikeev D, Glybochko P, Rapoport L, Taratkin M, Gross AJ, Vinnichenko V, Herrmann TRW, Netsch C. World J Urol. 2019 Sep 12. doi: 10.1007/s00345-019-02944-y. [Epub ahead of print] PubMed PMID: 31515606.
3. HOW LASERS ABLATE STONES: IN VITRO STUDY OF LASER LITHOTRIPSY (HO:YAG AND TM-FIBER LASERS) IN DIFFERENT ENVIRONMENTS. Taratkin M, Laukhtina E, Singla N, Tarasov A, Alekseeva T, Enikeev M, Enikeev D. J Endourol. 2020 Jan 29. doi: 10.1089/end.2019.0441. [Epub ahead of print]. PMID: 31885281.
4. PRECLINICAL COMPARISON OF SUPERPULSE THULIUM FIBER LASER AND A HOLMIUM:YAG LASER FOR LITHOTRIPSY. Andreeva V, Vinarov A, Yaroslavsky I, Kovalenko A, Vybornov A, Rapoport L, Enikeev D, Sorokin N, Dymov A, Tsarichenko D, Glybochko P, Fried N, Traxer O, Altshuler G, Gapontsev V. World J Urol. 2020 Feb;38(2):497-503. doi: 10.1007/s00345-019-02785-9. Epub 2019 May 4. PMID: 31055626. 
5. TEMPERATURE CHANGES DURING LASER LITHOTRIPSY WITH HO:YAG LASER AND NOVEL TM-FIBER LASER: A COMPARATIVE IN-VITRO STUDY. Taratkin M, Laukhtina E, Singla N, Kozlov V, Abdusalamov A, Ali S, Gabdullina S, Alekseeva T, Enikeev D. World J Urol. 2020 Feb 20. doi: 10.1007/s00345-020-03122-1. [Epub ahead of print]. PMID: 32078706.
6. THULIUM-FIBER LASER FOR LITHOTRIPSY: FIRST CLINICAL EXPERIENCE IN PERCUTANEOUS NEPHROLITHOTOMY. Enikeev D, Taratkin M, Klimov R, Alyaev Y, Rapoport L, Gazimiev M, Korolev D, Ali S, Akopyan G, Tsarichenko D, Markovina I, Ventimiglia E, Goryacheva E, Okhunov Z, Jefferson FA, Glybochko P, Traxer O. World J Urol. 2020 Feb 27. doi: 10.1007/s00345-020-03134-x. [Epub ahead of print] Review. PMID: 32108256.
7. Superpulsed thulium-fiber laser for stone dusting - in search of perfect ablation regimen. A prospective single center study. Enikeev D, Taratkin MS, Klimov R, Inoyatov J, Azilgareeva C, Ali S, Korolev D, Corrales M, Traxer O, Glybochko PV. Journal of Endourology. DOI: 10.1089/end.2020.0519.
8. The impact of the laser fiber-tissue distance on histological parameters in a porcine kidney model. Taratkin M, Netsch C, Enikeev D, Gross AJ, Herrmann TRW, Korolev D, Laukhtina E, Glybochko P, Becker B. World Journal of Urology. DOI: 10.1007/s00345-020-03326-5.
9. A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery. Enikeev D, Traxer O, Taratkin M, Okhunov Z, Shariat S. Curr Opin Urol. 2020 Nov;30(6):853-860. doi: 10.1097/MOU.0000000000000815.
10. Prospective Single-Center Study of SuperPulsed Thulium Fiber Laser in Retrograde Intrarenal Surgery: Initial Clinical Data. Taratkin M, Azilgareeva C, Korolev D, Barghouthy Y, Tsarichenko D, Akopyan G, Chinenov D, Ali S, Kozlov V, Mikhailov V, Enikeev D. Urol Int. 2021 Jun 16:1-7. doi: 10.1159/000516933. Epub ahead of print.
11. Re: Panthier et al., Pulsed lasers and endocorporeal laser lithotripsy, Progrès en Urologie, 2021. Enikeev D. Prog Urol. 2021 Jun-Jul;31(8-9):449-450. doi: 10.1016/j.purol.2020.12.011.
12. Retrograde intrarenal surgery versus percutaneous nephrolithotomy in larger kidney stones. Could SuperPulsed Thulium-fiber laser change the game? Taratkin M, Azilgareeva C, Chinenov D, Mikhailov V, Inoyatov J, Ali S, Korolev D, Tsarichenko D, Corrales M, Enikeev D. Cent European J Urol. 2021;74(2):229-234. doi: 10.5173/ceju.2021.0133. Epub 2021 May 16. PMID: 34336243; PMCID: PMC8318030.
13. Endoscopic lithotripsy with a SuperPulsed thulium- fiber laser for ureteral stones: A single-center experience. Enikeev D, Grigoryan V, Fokin I, Morozov A, Taratkin M, Klimov R, Kozlov V, Gabdullina S, Glybochko P. Int J Urol. 2021 Mar;28(3):261-265. doi: 10.1111/iju.14443. Epub 2020 Nov 30. PMID: 33258271.
14. Minimally invasive percutaneous nephrolithotomy with SuperPulsed Thulium-fiber laser. Korolev D, Akopyan G, Tsarichenko D, Shpikina A, Ali S, Chinenov D, Corrales M, Taratkin M, Traxer O, Enikeev D. Urolithiasis. 2021 Oct;49(5):485-491. doi: 10.1007/s00240-021-01258-2. Epub 2021 Mar 3. PMID: 33655346.
15. Superpulse thulium fiber laser lithotripsy: an in vitro comparison of 200 μm and 150 μm laser fibers. Taratkin M, Azilgareeva C, Corrales M, Teoh JY, Allenov S, Inoyatov J, Ali S, Rivas JG, Markovina I, Enikeev D. World J Urol. 2021 Dec;39(12):4459-4464. doi: 10.1007/s00345-021-03800-8. Epub 2021 Aug 15. PMID: 34392390.
16. Re.: Temperature rise during ureteral laser lithotripsy: comparison of superpulse thulium fiber laser (SPTF) vs. high- power 120 W holmium-YAG laser (Ho:YAG). Taratkin M, Herrmann TRW, Enikeev D. World J Urol. 2022 May;40(5):1259-1260. doi: 10.1007/s00345-021-03852-w. PMID: 34686900.
17. A novel and less traumatic needle for kidney puncture: development and preclinical study results. Morozov A, Kalinin N, Androsov A, Gazimiev A, Lerner Y, Gómez Rivas J, Somani BK, Enikeev D, Gazimiev M. J Endourol. 2022 Sep 8. doi: 10.1089/end.2022.0371. PMID: 36074948.
18. A novel and less traumatic needle for kidney puncture: development and preclinical study results. Morozov A, Kalinin N, Androsov A, Gazimiev A, Lerner Y, Gómez Rivas J, Somani BK, Enikeev D, Gazimiev M. J Endourol. 2022 Sep 8. doi: 10.1089/end.2022.0371. PMID: 36074948.
19. Thulium fiber laser vs Ho:YAG in RIRS: a prospective randomized clinical trial assessing the efficacy of lasers and different fiber diameters (150 µm and 200 µm). Taratkin M, Azilgareeva C, Petov V, Morozov A, Ali S, Babaevskaya D, De Coninck V, Korolev D, Akopyan G, Scoffone CM, Chinenov D, Androsov A, Fajkovic H, Lifshitz D, Traxer O, Enikeev D. World J Urol. 2023 Dec;41(12):3705-3711. doi: 10.1007/s00345-023-04651-1.
20. A nomogram to predict "pure" vs. "mixed" uric acid urinary stones. Zieber L, Creiderman G, Krenawi M, Rothenstein D, Enikeev D, Ehrlich Y, Lifshitz D. World J Urol. 2024 Oct 31;42(1):610. doi: 10.1007/s00345-024-05340-3. PMID: 39480595.
21. Safety and efficacy of laser lithotripsy for treatment of bladder calculi: evidence from a systematic literature review. Akram M, Cerrato C, Enikeev D, Tokas T, Somani BK. Curr Opin Urol. 2024 Nov 14. doi: 10.1097/MOU.0000000000001250. PMID: 39774916.

1. Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis. Huang J, Chan SC, Tin MS, Liu X, Lok VT, Ngai CH, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Chiu PK, Ng AC, Enikeev D, Nicol D, Spiess PE, Laguna P, Teoh JY, Wong MCS. Eur Urol Oncol. 2022 Jul 18:S2588-9311(22)00111-0. doi: 10.1016/j.euo.2022.06.009. PMID: 35863988.
2. Survival outcomes and molecular drivers of testicular cancer in hispanic men. Rezaee ME, Elias R, Li HL, Agrawal P, Pallauf M, Enikeev D, Ged Y, Eggener S, Singla N. Urol Oncol. 2024 Sep;42(9):293.e1-293.e7. doi: 10.1016/j.urolonc.2024.04.024. Epub 2024 May 31. PMID: 38821727.

1. CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT OF ACUTE PYELONEPHRITIS IN PREGNANCY. Alyaev Yu.G., Gazimiev M.A., Enikeev D.V. Urologiya. 2008. No1. p. 1-7. 
2. CURRENT APPROACHES TO DIAGNOSIS OF ACUTE PYELONEPHRITIS. Alyaev Yu.G., Gazimoev M.A., Enikeev D.V. Vrach. 2009. No 6. p. 76-78. 
3. ACUTE CALCULOUS PYELONEPHRITIS TREATMENT. Alyaev Yu.G., Enikeev D.V. Saratovskiy nauchno-meditsinsky zhurnal. 2011. No7(S2). p. 115.
4. ACUTE PYELONEPHRITIS IN PREGNANCY: MODERN ASPECTS OF DIAGNOSIS AND TREATMENT. Enikeev D.V., Spivak L.G. Consilium Medicum. 2016; 07: 49-54
5. IMAGING TECHNOLOGIES IN THE DIAGNOSIS AND TREATMENT OF ACUTE PYELONEPHRITIS. Enikeev DV, Glybochko P, Alyaev Y, Enikeev M, Rapoport L. Urologia. 2017 Aug 1;84(3):179-184. doi: 10.5301/uj.5000234. Epub 2017 May 18.

1. EAU-YAU Sexual and Reproductive Health Working Group. A systematic review and meta-analysis of placebo effect in clinical trials on chronic prostatitis/chronic pelvic pain syndrome. Morozov A, Bazarkin A, Babaevskaya D, Taratkin M, Kozlov V, Suvorov A, Spivak L, McFarland J, Russo GI, Enikeev D. Prostate. 2022 May;82(6):633-656. doi: 10.1002/pros.24311. PMID: 35133667.

1. Radio wave electrotherapy with a radiofrequency of 448 khz for the treatment of patients with organic erectile dysfunction: a prospective, randomized, blind, Sham- controlled, parallel-group study. Chuvalov LL, Korolev DO, Azilgareeva KR, Taratkin MS, Olefir YV, Fiev DN, Lumpov IS, Gorobets YP, Enikeev DV, Rapoport LM, Enikeev ME. Urologiia. 2022 May;(2):54-58. Russian.
2. A systematic review and meta-analysis of the placebo effect on both semen quality and male infertility. Utigalieva E, Morozov A, Shoshany O, Suvorov A, Taratkin M, Manfredi C, Falcone M, Bezrukov E, Fajkovic H, Russo GI, Enikeev D; EAU-YAU Sexual and Reproductive Health Working Group. Minerva Urol Nephrol. 2024 Aug;76(4):423-435. doi: 10.23736/S2724-6051.24.05559-9. PMID: 39051890.

1. Artificial intelligence and simulation in urology. Gómez Rivas J, Toribio Vázquez C, Ballesteros Ruiz C, Taratkin M, Marenco JL, Cacciamani GE, Checcucci E, Okhunov Z, Enikeev D, Esperto F, Grossmann R, Somani B, Veneziano D. Actas Urol Esp. 2021 Jun 11:S0210-4806(21)00088-7. doi: 10.1016/j.acuro.2020.10.012. Online ahead of print.
2. Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review. Bazarkin A, Morozov A, Androsov A, Fajkovic H, Rivas JG, Singla N, Koroleva S, Teoh JY, Zvyagin AV, Shariat SF, Somani B, Enikeev D.
   Curr Urol Rep. 2024 Jan;25(1):19-35. doi: 10.1007/s11934-023-01193-2.
3. Comprehensive consent in urology using decision aids, leaflets, videos and newer technologies: empowering patient choice and shared decision-making. Nedbal C, Naik N, Davis N, Madaan S, Tokas T, Cacciamani G, Ventimiglia E, Geraghty RM, Enikeev D, Somani BK. Ther Adv Urol. 2024 Nov 23; 16:17562872241301729. doi: 10.1177/17562872241301729. PMID: 39583573.

1. Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19. Enikeev D, Taratkin M, Efetov S, Shlomina A, Boldyreva M, Galkina I, Spivak L, Gitel E, Kuchieva A, Mikhailov V, Teoh JY, Herrmann TRW, Kikic Ž, Fomin V, Shariat SF, Glybochko P. Curr Opin Urol. 2021 Jul 1;31(4):363-368. doi: 10.1097/MOU.0000000000000901.
2. Consensus Statement on Urinary Stone Treatment During a Pandemic: A Delphi Process from the Endourological Society TOWER Research Initiative. Scotland KB, Tailly T, Chew BH, Bhojani N, Smith D; TOWER Initiative. J Endourol. 2022 Mar;36(3):335-344. doi: 10.1089/end.2021.0477. PMID: 35019782.
3. Prospective two-arm study of the testicular function in patients with COVID-19. Enikeev D, Taratkin M, Morozov A, Petov V, Korolev D, Shpikina A, Spivak L, Kharlamova S, Shchedrina I, Mestnikov O, Fiev D, Ganzha T, Geladze M, Mambetova A, Kogan E, Zharkov N, Demyashkin G, Shariat SF, Glybochko P. Andrology. 2022 Sep;10(6):1047-1056. doi: 10.1111/andr.13159.
4. A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond. Leow JJ, Tan WS, Tan WP, Tan TW, Chan VW, Tikkinen KAO, Kamat A, Sengupta S, Meng MV, Shariat S, Roupret M, Decaestecker K, Vasdev N, Chong YL, Enikeev D, Giannarini G, Ficarra V, Teoh JY; UroSoMe Collaborators. Front Surg. 2022 Oct 4;9:879774. doi: 10.3389/fsurg.2022.879774